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Summary 
Numerous epidemiological studies have indicated that a diet rich in plant based foods 
reduces the risk of several chronic diseases. The beneficial health effects of eating dietary 
plants have been proposed to be partly mediated by the phytochemicals found within these 
foods. Several dietary phytochemicals can induce EpRE-dependent transcription which is 
essential in up-regulation of cytoprotective proteins, and this has been suggested to be one of 
the mechanisms by which phytochemicals may provide protection against chronic diseases. 
Dietary phytochemicals have been postulated to work in synergistic and additive manners, 
and thus this thesis investigated the effects of combinations of plant extracts on EpRE-
dependent transcription in vitro. A potent inducer from the in vitro studies was furthermore 
tested in vivo in transgenic mice. 
Of 11 extract combinations tested in vitro, 8 gave a statistically significant induction of 
EpRE-dependent transcription, and 7 of these were also statistically significantly higher than 
one or both of the separately added extracts. Most of the extract combinations appeared to 
exert additive effects, although some showed a trend toward a more synergistic or 
antagonistic effect. One of the combinations with the strongest EpRE induction and a trend 
towards synergistic effect was tested in a wider range of concentrations. In this extended 
experiment, trends towards antagonistic effects were observed. 
A rosemary extract was used for an in vivo experiment with EpRE-LUC mice. For the mice 
given rosemary, the EpRE-dependent luciferase activity measured by in vivo imaging was 
significantly higher than the control mice 5h after gavage feeding. Furthermore, a trend 
towards increased EpRE activity in the intestine was found for the extract group compared to 
the control group. 
Based on these results, further studies on effects of combinations of dietary plants on EpRE-
dependent transcription and dietary effects of EpRE activity in vivo are warranted. 
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1. Introduction 
1.1 Diet and health 
The diet is an important factor in the promotion and maintenance of a good health. 
Diet-related disorders range from neural tube defects in the unborn child, to age-
related chronic diseases such as heart disease, cancer, hypertension, stroke, and type 
II diabetes (1;2). In the western world, classical deficiency symptoms caused 
exclusively by malnutrition occur rarely today (1;2). The prevalence and incidence of 
dietary related chronic diseases however, are increasing (2). 
According to the World Health Organization (WHO), chronic diseases are the leading 
cause of death today, representing 60 % of all deaths (2). In 2005, 30 million people 
died from chronic diseases, and without any action the deaths from chronic diseases 
are expected to increase by 17 % over the next ten years (3). Due to the significant 
impact of the diet on the risk of developing chronic diseases, the diet is one of the 
most important modifiable factors in the globally increasing burden of chronic 
diseases. WHO has therefore stated that the strategies and policies that are applied in 
prevention of chronic diseases must fully recognize the essential role of the diet (2). 
Dietary plants and health 
Epidemiological studies have indicated that a high consumption of fruits, vegetables 
and whole grains is strongly associated with reduced risk of developing chronic 
diseases such as cancer, cardiovascular disease, diabetes, cataracts and Alzheimer 
disease (4-7). A diet rich in fruits, vegetables and whole grains may provide health 
benefits beyond basic nutrition, and a healthy diet seemingly depends on more than 
meeting the nutritional recommendations for macro-and micronutrients (8). A long 
with recommendations for a diet well balanced in macro- and micronutrients, a high 
consumption of fruit and vegetables has therefore been emphasized as a global 
priority in the prevention of chronic diseases (7). 
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In addition to important nutrients, such as vitamin C, vitamin E, folate, dietary fibre 
and different trace metals, dietary plants also contain several non-nutrient bioactive 
compounds such as phytochemicals (9). Several phytochemicals have been shown 
either in epidemiological or in vitro studies to have potential health benefits , and it is 
widely believed that phytochemicals are contributing to the beneficial health effects 
of a diet high in fruits and vegetables (7). A number of phytochemicals have been 
isolated and used as dietary supplements. It however appears as though the beneficial 
health effect observed for whole dietary plants can not be directly reproduced with 
one or a few of these pure compounds. Although observational studies suggests that 
people with a high intake of fruit and vegetables containing β-carotene have a lower 
risk of developing cancer and cardiovascular disease, randomized, double-blind and 
placebo controlled trials with β-carotene supplements have not supported these 
findings (10). It has therefore been suggested that several compounds are contributing 
simultaneously to the beneficial health effect of dietary plants. These beneficial 
effects can thus not be found when using only one, or a few, isolated compounds 
from dietary plants. 
Despite the relatively consistent relationship between a high consumption of dietary 
plants and reduced risk of chronic diseases, the mechanisms behind the beneficial 
health effect of dietary plants are not fully elucidated. During the past decade, there 
has however been a rapid expansion of a number of scientific methods that are used 
to study molecular mechanisms by which dietary plant compounds may affect human 
physiology. This will contribute to extended knowledge of the mechanism behind the 
beneficial health effects of dietary plants, and possibly lead to more specific 
recommendations with respect to intake of dietary plant foods. 
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1.2 Dietary phytochemicals 
Phytochemicals is a collective term for a variety of plant components found to have 
important functions in plants (7). Phytochemicals provides colour and flavour, and 
exert protection against herbivores, pathogens, ultra violet (UV) radiation in dietary 
plants (11). Numerous phytochemicals have been identified, several with strong 
antioxidant capacity, and a wide range of these compounds may be provided by one 
serving of vegetables (9). 
Phytochemicals (other than the vitamins) are not essential to humans, and are thus 
generally defined as non-nutrient compounds (12). Due to their protective functions 
in plants however, phytochemicals have been linked to the beneficial health effect of 
a diet high in dietary plants (8;13). 
1.2.1 Classification  
The phytochemicals are classified based on to their chemical structure and functional 
characteristics (7). According to Liu, the main classes are carotenoids, phenolics, 
alkaloids, nitrogen-containing compounds, and organosulphur compounds (Figure 
1.1) (14). 
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Figure 1.1 Overview of the phytochemical subdivisions (adapted from Liu (14)) 
Carotenoids 
The carotenoids are naturally fat-soluble pigments, which have received great 
attention because of their pro-vitamin A and antioxidant function (14). The 
subclasses, chemical structure, and sources of the most common carotenoids are 
presented in Table 1.1. The α-carotene, β-carotene, and β-cryptoxanthin can function 
as pro-vitamin A. Lutein and zeaxanthin are the major carotenoids in the macular 
region of the retina in humans (14), while astaxanthin is the pigment providing 
certain fish and crustaceans, e.g. salmon and lobsters, with their reddish color (15). 
Nearly a thousand naturally-occurring carotenoid pigments have been identified, 
occurring in plants, microorganisms and animals (16). Their structure contains 
conjugated double bonds, which enable them to function as pigments (14). The 
conjugated structure also enables the carotenoids to quench singlet oxygen by 
transferring the excitation energy from 102 to a carotenoid, leaving the oxygen at a 
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ground state and dissipating thermal energy to the surroundings to restore the ground 
state carotenoid (17). This provides photosynthetic systems with protection against 
oxidative damage, and it has further been suggested that carotenoids may also exert 
protection against damage by UV-light in the humans (18;19). The structure also 
enables the carotenoids to be incorporated within lipid membranes and proteins (20), 
and carotenoids may thus modify the fluidity and reduce oxidative degeneration of 
these (16). Carotenoids may however also function as pro-oxidants under certain 
conditions, and the effect of carotenoids as antioxidants/pro-oxidants needs further 
investigation (21). Specific carotenoids have further been suggested from 
epidemiological studies to have a cancer protective role, such as lycopene indicated 
to reduce the risk of prostate cancer (22). 
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Table 1.1 Carotenoids (14;15;23;24) 
 
Phenolics 
Phenolics are products of secondary metabolism in plants, in which they appear to act 
as defense mechanisms and contribute to the color (14;25). The phenolics comprise a 
wide variety of complex molecules with both monophenol and polyphenol structure, 
generally categorized according to the number of phenol rings and the structural 
elements that bind these rings together (14) (Table 1.2). 
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Table 1.2 Phenolics (14) 
Phenolics 
Class Group Chemical structure Examples 
(See also figure 1.1) 
Dietary Sources 
Flavonols 
 
Quercetin 
Kaempherol 
Myricetin 
Galangin 
Fisetin 
Onion, blue berries 
broccoli, tea, red 
wine 
Flavones  Apigenin 
Chrysin 
Luteolin 
 
Parsley, celery, 
cereals, citrus fruit 
skin 
Flavanones 
 
Eriodictyol 
Hesperitin 
Naringenin 
 
Citrus fruits, 
tomatoes, mint plant 
Flavanols 
 
Catechins Green tea, chocolate, 
fruits (apricots 
especially), wine 
Anthocyanidins  Cyanidin 
Pelargonoidin 
Delphinidin 
Malvidin 
Berries, red wine, red 
cabbage, red onions, 
radishes  
Flavonoids 
Isoflavones  Genistein 
Daidzein 
Glycitein 
Formononetin 
Leguminous plants; 
soy products 
Hydroxybenzoic 
acid 
 Gallic acid Red fruits, black 
radish, onions, tea 
Phenolic acid 
Hydrocinnamic 
acid 
 p-coumaric acid 
Sinapic acid 
Cafeic acid 
Ferulic acid 
Coffee, blueberry, 
kiwi, cherry, plum, 
apple, grains 
Lignans   Matairesinol 
Secoisolariciresinol 
Linseed, cereals, 
grains, fruits (pears, 
prunes), vegetables 
(garlic, aspargeous, 
carrots) 
Stilbenes  
 
Resveratrol Grapes, red wine. 
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A wide range of phenolics are found within dietary plants, and the phenolic content 
of several food items have been published and reviewed (26;27). The main sources of 
polyphenols are fruit and beverages such as tea, coffee and red wine. Whereas some 
phenolics are specific to particular foods (e.g. isoflavones in leguminous fruit), others 
are found in many types of plant products (quercetin in juice, vegetables, cereals etc.) 
(28). It has been estimated that two thirds of consumed phenolics are provided by the 
flavonoids, while the remaining one third is provided by phenolic acids (14). 
Epidemiological studies have indicated that phenolics may protect against major 
chronic diseases, such as cardiovascular disease (24), diabetes type II (29), cancer of 
the gastrointestinal tract (30), breast, and prostate (31), in addition to improving brain 
function (32). 
Alkaloids 
The alkaloids are nitrogen-containing secondary metabolites derived from amino 
acids, which are assumed to contribute to plants defence against herbivores and 
pathogens (33). Alkaloids occur in 20 % of plant species (34;35), and have been 
investigated as pharmaceuticals, stimulants, narcotics and poisons (33). Some of the 
most studied alkaloids are the purine alkaloids methylxanthines and methyluric acids, 
found in tea, coffee and other non-alcoholic beverages (36) (Table 1.3). 
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Table 1.3 Alkaloids (36)  
Alkaloids 
Class Group Chemical structure Compound 
 
Dietary Sources 
Theophyllin  
 
Tea, maté 
Paraxanthin 
 
Coffee 
Theobromine 
 
Cacao, tea, coffee, 
maté 
Methylxanthines  
Caffeine Coffee, guarana, tea,
mate, citrus fruit  
  
Theacrine  
 
Chinese tea (kucha) 
Liberine 
 
Coffee, tea 
Purine alkaloids 
Uric acids and 
methyluric acids 
 
Methylliberine  
 
Coffee 
 
Caffeine, a central nervous stimulant (37), has been offered special research attention. 
Many diseases have been associated with caffeine and coffee consumption in 
previous epidemiological studies (e.g. psychiatric diseases, coronary heart disease, 
and pancreatic cancer) (37). Recent studies however, have suggested that previous 
studies may have been confounded, and data on potential health benefits of coffee in 
cancer-prevention have increased during the last decades (38). To what extent 
caffeine may contribute to this effect is however not fully elucidated. 
Nitrogen-containing compounds  
The nitrogen-containing compounds within foods have been relatively poorly 
investigated. Such compounds have been extracted from different plant species used 
in herbal medicine, and are considered by some to be the bioactive compounds 
behind the potential health effect of these medicines (39). Nitrogen-containing 
compounds such as indole-3-carbinol, can be found in cruciferous vegetables, a 
vegetable group associated with a decreased incidence of cancer in humans (40) 
(Table 1.4). 
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Organosulphur compounds  
Organosulphur compounds are naturally occurring sulphur containing compounds, 
found in foods such as garlic, mustard and cruciferous vegetables (41;42). Some of 
the organosulphur compounds have a sharp taste which provides the characteristic 
taste of their respective vegetables (Table 1.4). 
Epidemiologic studies have indicated a beneficial health effect of the allium family of 
vegetables containing garlic and onion, and this has been coupled to their 
organosulphur compounds (43). The organosulphur compounds within garlic have 
been found to have beneficial effects in vitro as inhibitors of platelet aggregation (41) 
and tumour cell proliferation (42). Isothiocyanates, the dominating sulphur-
containing components of mustard, horse raddish and some cruciferous vegetables, 
have also been proposed and investigated as potentially chemopreventive compounds 
(reviewed in (44)). 
Table 1.4 Organosulphur and nitrogen-containing compounds (14;41;42) 
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1.2.2 Bioavailability of phytochemicals  
Bioavailability describes the amount of an ingested compound that reaches the 
systemic circulation (12) (Figure 1.2). Bioavailability is therefore an essential aspect 
when studying potential health effects of dietary phytochemicals. 
Many factors affect the bioavailability, and these factors can be divided into two 
distinct categories. The first category includes exogenous factors, such as the 
complexity of the food matrix, the chemical composition of the food, and other 
compounds consumed at the same time. The second category includes endogenous 
factors such as the rate of gastric emptying, intestinal transit time, amount of enzymes 
in the intestine, and the metabolism of the compounds (12). 
A prerequisite for any compound to be bioavailable is that they are bioaccessible 
from the intestinal lumen (12). Bioaccessibility is defined as the amount of the 
substance that is potentially absorbable from the intestine, and can be highly 
influenced by the food matrix, co-ingested compounds, food processing and gastric 
and luminal digestion. The bioaccessibility of carotenoids for example have been 
shown to be greatly improved by cooking and pureeing (45), and, due to their fat-
soluble characteristic, by addition of oil to the meal (46). Phytochemicals further 
occur in a large number of structurally different compounds, of which several need to 
be modified before absorption (12). Phenolics are commonly present in food as 
esters, glycosides, or polymers, and need to be hydrolyzed by food processing, 
intestinal enzymes, or the colonic microflora to be absorbed. 
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Figure 1.2 Model of the absorption and distribution of foods (modified from Holst and 
Williamson (12)). 
Compared to most nutrients, the bioavailability of phytochemicals is relatively low 
(12). This is partly due to the fact that phytochemicals are recognized and handled by 
the body as xenobiotics (47). Although the liver was assumed to be the main site of 
xenobiotic metabolism originally, the small intestine has been found to have a 
significant capacity of xenobiotic metabolism and efflux (e.g. ABCC2 and p-
glycoprotein) (12). Metabolism and efflux in the small intestine may therefore limit 
the absorption of dietary phytochemicals significantly (48). Absorbed phytochemicals 
may be further modified by xenobiotic metabolism after absorption, thus the 
molecular characteristics of phytochemicals found in the circulation is often quite 
different from the molecular forms found in food (49). Phenolics may be modified 
into conjugates (e.g. sulfates and glucuronates) of the original parent aglycone (47). 
The biological activity of these metabolized compounds may be increased, but 
appears more often to be decreased (12). 
The phytochemicals that are not absorbed in the small intestine reach the large 
intestine where they may be hydrolyzed by the microflora (12). These metabolites 
 23
can be absorbed, and the bioavailability of certain phytochemicals actually seems to 
depend on the individual composition of the colon microflora (e.g. daidzein) (50). 
A significant amount of consumed phytochemicals will not be absorbed. This fraction 
may however still exert beneficial health effects through its presence in the intestine, 
as local effects in the large intestine have been suggested to influence the “systemic 
health” (12;51). This may occur by elimination of reactive species present in the large 
intestine (52), and several studies have shown that dietary phytochemicals may 
reduce peroxidation of polyunsaturated lipids in the gastrointestinal tract (reviewed in 
(51)). 
As for the absorption and metabolism, the elimination of phytochemicals follows the 
same route as xenobiotics. The elimination mainly occurs through two pathways; via 
bile or urine (12). For extensively conjugated metabolites, the elimination is more 
likely to be through the bile, while small conjugates are excreted through the urine 
(49). 
1.3 Genetic regulation 
Nutrients and gene regulation 
Nutrients may affect cellular signalling systems that regulate gene expression through 
different transcription factors (53). In addition to the relatively well established 
influence of vitamin A and D, dietary compounds such as fatty acids (54), glucose 
(55), and several phytochemicals (56), have been shown to influence gene 
expression. The most studied nutrients and their target transcription factors are 
presented in Table 1.5. 
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Table 1.5 Transcription factors influenced by nutrients (adapted from Muller et al. (53)) 
 
Transcription-factor pathways mediating nutrient-gene interactions 
Nutrient Compound Transcription factor 
Macronutrients  
Fats Fatty acids 
Cholesterol 
PPARs, SREBPs, LXR, HNF4, ChREBP 
SREBPs, LXRs, FXR 
Carbohydrates Glucose USFs, SREBPs, ChREBP 
Proteins Amino acids C/EBPs 
Micronutrients 
Vitamins Vitamin A 
Vitamin D 
Vitamin E 
RAR, RXR 
VDR 
PXR 
Minerals Calcium 
Iron 
Zinc 
Calcineurin/NF-ATs 
IRP1, IRP2 
MTF1 
Other food components 
 Flavonoids 
Sulphoraphane 
Xenobiotics 
ER, NFkB, AP1 
Nrf2 
CAR, PXR 
AP1, activating protein 1; CAR, constitutively active receptor; C/EBP, CAAT/enhancer binding protein; 
ChREBP, carbohydrate responsive element binding protein; ER, oestrogen receptor; FXR, farnesoid X receptor; 
HNF, hepatocyte nuclear factor; IRP, iron regulatory protein; LXR, liver X receptor; MTF1, metalresponsive 
transcription factors; NFkB, nuclear factor кB; NF-AT, nuclear factor of activated T cells; Nrf2, Nuclear factor 
E2 related protein 2; PPAR, peroxisome proliferator-activated receptor; PXR, pregnane X receptor; RAR, 
retinoic acid receptor; RXR, retinoid X receptor; SREBP, sterol-responsive-element-binding protein; USF, 
upstream stimulatory factor; VDR, vitamin D receptor. 
The influence of nutrients on gene expression has been suggested to have a 
significant role in the beneficial health effects of dietary plants (53). It is therefore a 
growing realization that we need to understand the effects of nutrition at the 
molecular level. The nutrigenomics has been developed as a new branch in nutritional 
research to study the genetic influence and cellular response of nutrients (53). 
Together with analysis of the proteome (proteomics) and the metabolome 
(metabolomics), nutrigenomics aims to increase the understanding of how nutrients 
influence the whole organism, and how such influences can affect the health. To 
understand the relationship between nutrients and genetic transcription however, 
basic gene regulation needs to be considered. 
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Basic gene regulation 
The nucleotides along the DNA strand codes for different genes. A gene is generally 
defined as a DNA segment that contains the instructions for making a particular 
protein (57). Genes consist of two functional parts: the coding region, containing the 
information needed to produce the gene-product; and the promoter, regulating the 
expression of the gene. 
The expression of genes can be regulated in many ways (Figure 1.3) (58), primarily 
at five different levels: (i) transcriptional control, (ii) during splicing and processing 
of the primary RNA transcript, (iii) during transport of the mRNA out of nucleus, (iv) 
during translation of the mRNA, or (v) by activation/inactivation of 
proteins.
Figure 1.3 Overview of the regulation of gene expression 
The promoter includes an initiation site, where the transcription actually starts, sites 
where general transcription factors bind, and a sequence approximately 50 bases 
upstream with sites where the RNA polymerase II initially attaches. In order to aid 
the assembly of general transcription factors and RNA polymerase onto chromosomal 
DNA, nearly all eukaryotic promoters require activator proteins. The DNA sites 
where these factors are bound are called “enhancers”, and these sites can reside 
thousands of nucleotide pairs away from the promoter. By looping and using other 
proteins as adaptors, the DNA allows the proteins to influence the events that take 
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place at the promoter. The repressor proteins however, prevent the assembly of the 
transcription complex and thus inhibit transcription. 
Gene activator and repressor proteins also exploit the chromatin structure to turn 
genes on or off. A tightly packed DNA will hamper access of the “transcription 
machinery” to the promoters, and nucleosomes may inhibit transcription if they are 
positioned over a promoter. By chromatin remodelling complexes and modification 
of the histone proteins, cells can alter the chromatin structure and render the DNA 
more or less accessible. Gene regulating proteins may utilize such mechanisms to 
alter the chromatin structure and allow greater (activator proteins) or less (repressor 
proteins) accessibility to the underlying DNA, resulting in an increased or reduced 
assembly of the general transcription factors and RNA polymerase at the promoter 
(58). 
In this thesis we study whether genetic regulation of the cytoprotective mechanisms 
of the body, such the antioxidant defence and detoxifying enzymes, can be affected 
by components from dietary plants. 
1.4 Cytoprotective mechanisms 
1.4.1 The antioxidant defence 
Our oxidative energy production takes place within the mitochondria (59). In this 
process, reactive oxygen species (ROS) are generated as byproducts. ROS, along 
with reactive nitrogen species (RNS) (Table 1.6), are also produced by other 
endogenous processes, such as inflammation, and may further be generated by 
exogenous stimuli, such as UV radiation, chemotherapeutic agents, hyperthermia and 
growth factors (60). 
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Table 1.6 Examples of reactive oxygen and nitrogen species (59). 
 
Reactive species play a dual role within the organism: they have beneficial effect, e.g. 
as defence against infectious agents, while they may also cause oxidative stress and 
be harmful (61). Their toxicity owes to their ability to react with molecular 
components within the cell, generating a radical chain reaction. This may cause loss 
of function of proteins, brakes and cross-linking of DNA, and peroxidation of lipids 
which affects the membrane fluidity (59). An overproduction of ROS and RNS may 
thus result in oxidative damage (61). Oxidative damage accumulates during life, and 
has been coupled to a number of age-dependent chronic diseases, such as cancer, 
arteriosclerosis, arthritis, and neurodegenerative disorders (59;61). 
Due to the damaging effects of reactive oxidative and nitrogen species, an effective 
antioxidant defence system has evolved. This defence is constituted by enzymatic and 
non-enzymatic components. The enzymatic system consists of superoxide dismutase 
(SOD), glutathione peroxidase (GP), glutathione reductase (GR), and catalase (CAT); 
while the non-enzymatic system consists of thioredoxin (Trx), lipoic acid, α-
tocopherol (vitamin E), ascorbic acid (vitamin C), selenium, glutathione (GSH), 
ferritin, albumin, transferrin, lactoferrin, ceruloplasmin, uric acid, and other 
antioxidants (60;61). The enzymatic antioxidant defence is mainly found 
intracellularly: SOD is found in the mitochondria and cytosol, GP in the cytosol and 
mitochondria, and CAT in the peroxisomes (60). For the non-enzymatic compounds 
however, some are found both intra- and extracellular (e.g. ferritin, α-tocopherol, 
ascorbic acid, GSH, lipoic acid, and other antioxidants); others are found largely 
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extracellular (e.g. transferrin, lactoferrin, ceruloplasmin, and uric acid); and some are 
mainly intracellular (e.g. Trx) (60;61). 
Dietary antioxidants 
Some dietary compounds exert antioxidant properties; for example ascorbic acid, 
tocopherols, and several phytochemicals (56). Some phytochemicals have further 
been shown to induce the endogenous antioxidant defence (e.g. sulphoraphane and 
curcumin), thus exerting antioxidant function in a more indirect way (62). The latter 
way may be especially efficient since it involves up-regulation of proteins and 
enzymes that are not consumed in the redox reaction, have long half-lives, and 
catalyze chemical reactions that lead to detoxification (62). Dietary compounds that 
both scavenge reactive species directly and also up-regulates the endogenous 
antioxidant defence, may provide extensive protection against oxidative damage (62). 
Due to the correlation between oxidative damage and disease, the wide variety of 
compounds with antioxidant properties in dietary plants has been proposed as one of 
the mechanisms behind the beneficial health effects of dietary plants (63). 
1.4.2 Xenobiotic metabolism 
To minimize potential injury caused by xenobiotics that are introduced into the 
human body, compounds perceived as xenobiotics undergo a sequential three-step 
metabolism (64): 
The first step is directed by the phase I enzymes. These enzymes consist primarily of 
the cytochrome P450 super-family, and catalyze reactions that introduce functional 
groups into hydrophobic organic molecules (65). In most cases the reaction products 
are inert metabolites, but sometimes the phase I enzymes produce highly reactive 
products harmful to biological molecules (e.g. strong electrophilic compounds) (62). 
The second step is directed by the phase II enzymes. These enzymes consist of 
several conjugating enzymes, such as glutathione S-transferase (GST), 
NADPH:quinone oxidoreductase (NQO1) (66) and UDP- glucuronosyltransferase 
(UGT)) (64). Conjugation of xenobiotic compounds by phase II enzymes generally 
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increases their hydrophilicity and enhances their excretion in the bile and/or the urine. 
The phase II enzymes thus exert a detoxifying effect. The xenobiotic metabolism has 
also been added a third step, called phase III, which consists of the efflux transporters 
(e.g. p-glycoprotein) that export the final metabolites. 
Damaging molecules produced by phase I metabolism can potentially be detoxified 
by phase II metabolism (62). The consequences of such damaging compounds may 
therefore depend on the balance between the phase I and phase II enzymes (67). 
Some carcinogens have been found to enter the body as unreactive pro-carcinogens 
dependent on phase I enzymes to be converted into highly reactive carcinogens (67). 
The consequences of these carcinogens may thus rely on the efficacy of the phase II 
enzymes, and carcinogen treated GST-knock out mice have correspondingly been 
shown to develop significantly more tumours than wild type littermates (68). 
Phase II enzymes have been found to be up-regulated by several different compounds 
(67). Induction of phase II enzymes has received great attention with respect to 
chemoprevention, and several chemopreventive compounds have been suggested to 
exert their chemoprevention by inducing phase II enzymes (for a review (69)). 
Oltipraz for example, a synthetic compound shown to have chemoprotective activity 
against several classes of carcinogens, has been shown to exert chemoprevention in 
mice by induction of phase II enzymes (70). 
1.4.3 EpRE-dependent transcription of cytoprotective proteins 
Together with the antioxidant defence, the phase II enzymes provide eukaryotic 
organisms with protection against damaging compounds such as oxidants and 
electrophiles (62). Interestingly, with respect to the preventive role of both of these 
systems, the inducers of phase II enzymes have been found to induce several 
components of the endogenous antioxidant defence as well (62). It has therefore been 
suggested that the components of these two cytoprotective systems should 
collectively be referred to as cytoprotective proteins (62). 
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As up-regulation of cytoprotective proteins may counteract the damaging effects of 
oxidants and electrophilic compounds, induction of these proteins may to be an 
effective means in the prevention of chronic diseases (62). Potent inducers have been 
found, and a special characteristic of these inducers was revealed by Talalay et al. 
(71), showing that the majority contain, or acquire by metabolism, an electrophilic 
centre. 
Inducers of cytoprotective proteins may be divided into two main classes: The first 
class is called bifunctional inducers, and consists of planar aromatic compounds, e.g. 
polyaromatic hydrocarbons (PAH) and flavonoids, that up-regulate certain phase I 
enzymes in addition to cytoprotective proteins. The second class is called 
monofunctional inducers, and consists of compounds (e.g. sulphoraphane, cinnamates 
and coumarins), which exclusively up-regulate cytoprotective proteins. Due to the 
potential activation of pro-carcinogens by phase I enzymes, the monofunctional 
inducers have been assumed to provide more beneficial health effects than the 
bifunctional inducers (67). 
In studies trying to elucidate the molecular mechanisms by which the monofunctional 
inducers up-regulate cytoprotective proteins, the 5’ flanking region of the rat (72) and 
mouse (73) GST Ya subunit gene was found to contain a similar 41-bp DNA 
fragment. The DNA fragment had the consensus sequence 
5’-TA/CANNA/GTGAC/TNNNGCA/G-3’ (74), and was located between base pair -754 
and -713 in the mouse (73), and -682 and -722 in the rat GST Ya gene (72). The 
DNA fragment was further found to activate transcription of the GST gene in 
response to an electrophilic signal (75). Subsequent studies have identified the 
sequence within several promoters of cytoprotective proteins, such as mouse HO-1 
(76), rat and human NAD(P)H:quinine oxidoreductase (NQO1) (77;78), human γ-
glutamylcysteine synthetase (GCS) (79), and Trx (80), in addition to the promoter of 
nuclear factor E2-related protein 2 (Nrf2) (81). These cytoprotective proteins may be 
transcriptionally induced through this enhancer element (62). The enhancer element 
is referred to as both the “antioxidant-responsive element” (ARE), and the 
“electrophile-responsive element” (EpRE). This thesis will use the term EpRE. 
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Regulation of EpRE-dependent transcription 
Nrf2  
In order for EpRE-dependent transcription to be induced, transcription factors need to 
associate with EpRE. The proteins in the Cap’n’Collar (CNC) family of basic region 
leucine-zipper (bZIP) transcription factors have been found able to activate EpRE-
dependent transcription (82). The NF-E2-related factor 2 (Nrf2) of this family 
appears to be the main transcription factor involved in induction of cytoprotective 
proteins through EpRE (83). A study showed that Nrf2-deficient mice develop more 
spontaneous gastric tumours, and have no preventive effect of the chemo-protective 
compound oltipraz against carcinogen induced tumorigenesis (70). Nrf2 is expressed 
in an ubiquitously manner, but is expressed in rather high amounts in the intestine, 
lung and kidney where detoxification reactions occur routinely (83). 
Nrf2 normally resides in the cytosol, but translocates to the nucleus upon activation 
by inducers of EpRE-dependent transcription (84). In nucleus Nrf2 associates with 
other transcription factors, and bind to EpRE as heterodimers with small Maf 
(Musculoaponeurotic fibrosarcoma) bZIP proteins, e.g MafG and MafK (83). Nrf2 is 
also described to interact with the co-activator CREB binding protein (CBP) before 
DNA-binding (85). The DNA bound Nrf2 complex recruits the basal transcriptional 
machinery and activates transcription of cytoprotective proteins (86). 
 
Figure 1.4 A model of the Nrf2 structure (87). 
Nrf2 contains six highly conserved regions, named Nrf2-ECH homology (Neh) 
domain 1 to 6 (Figure 1.4): Neh1 contains a CNC homology region and a bZIP 
domain; Neh2 and Neh3 contains the amino and carboxyl termini respectively; Neh4 
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and Neh5 are two acidic domains, shown to be important for CBP binding and 
transcriptional activation, while; Neh6 contains a conserved serine-rich region 
(83;88). The Neh2 domain has been shown to be necessary to retain Nrf2 in the
cytoplasm and repress its activity under basal conditions (88). This repression is 
mediated by a protein called Kelch-like ECH-associated protein 1 (Keap1), and th
Nrf2 Neh2 domain has been found to contain two motifs, ETGE and DLG, by which
Keap1 recognizes and binds to Nrf2 (87). 
 
e 
 
Keap1 
 a cytoskeleton-bound cysteine-rich zinc-metalloprotein (84) which is widely 
 
 
Figure 1.5 Model of the Keap1 structure (87). 
Keap1 contains five distinct domains (90) (Figure 1.5). The first domain consists of 
s 
ifth 
Keap1 is
expressed in various cell lines and tissues (88). Keap1 has been suggested to function 
as an adaptor protein for a ubiquitin ligase that targets lysine residues in the Neh2 
domain, marking Nrf2 for degradation by the 26S proteasome (89). Thus, Keap1 
regulates the steady state level of Nrf2, and maintains a low activation of EpRE-
dependent transcription under basal conditions. 
the amino-terminal region (NTR). The second domain contains a BTB/POZ (bric-a-
brac, tramtrack, broad complex/Poxvirus zink finger) domain, by which Keap1 form
homodimers and probably associates with the ubiquitin ligase (89). The third domain 
consists of a cysteine-rich intervening region (IVR), also found to possibly interact 
with the ubiquitin ligase (90). The fourth domain consists of the double glycine 
repeat (DGR), also known as the Kelch domain, shown to be responsible for the 
binding of Keap1 to the cytoskeleton and to the Neh2 domain of Nrf2 (90). The f
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domain consists of a short carboxy terminal domain (CTR), probably also involved in 
the binding to Nrf2 (87). 
Homodimers of Keap1 bind with an overlapping binding surface of its DGR and 
CTR domains (Keap1-DC) to the ETGE and DLG motifs of Neh2; one monomer to 
each motif, but with a higher binding affinity for the ETGE motif (87). 
Regulation of the Nrf2 release and translocation 
In order to induce EpRE-dependent transcription, Nrf2 needs to be stabilized, 
dissociated from Keap1, and translocated to the nucleus (91). It is widely accepted 
that Nrf2 can accumulate in nucleus after exposure to oxidative stress or EpRE 
inducers (86;91), but the mechanisms by which this occur are not fully understood. 
Different mechanisms have been suggested, and both modification of Keap1 cysteine 
residues and phosphorylation and regulation of the transactivation activity of Nrf2 
has been proposed as possible mechanisms (Figure 1.6) (86). 
 
Figure 1.6 Model of Nrf2 regulation (92) 
Modification of cysteine residues on Keap1 
Most inducers of EpRE-dependent transcription contain electrophilic moieties that 
are capable of reacting with sulfhydryl groups; such as reactive cysteine residues 
(91). While the Neh2 domain bound to Keap1 lacks modifiable cysteine residues, 
Keap1 contains several of such, and its characteristic as a Nrf2-repressor has been 
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shown to be impeded by oxidative and electrophilic modification of some of these 
(93). Modification of cysteines on Keap1 by electrophilic inducers however appears 
to be insufficient to disrupt the complex between Keap1 and Nrf2 (94). Induction of 
EpRE-dependent transcription via modification of cysteine residues on Keap1 is 
rather suggested to be mediated by stabilization of Nrf2 through disruption of its 
ubiquitination and proteasomal degradation (95). 
Between the two Keap1 binding motifs in the Neh2 domain of Nrf2, there is a α-helix 
containing seven lysine residues which have been shown to be necessary for the Nrf2 
ubiquitination mediated by Keap1 (89). Correct spatial positioning between the target 
lysine residues and the ubiquitin ligase is important, and a distortion of this 
positioning may inhibit ubiquitination and degradation of Nrf2. The binding of the 
two Neh2 recognition motifs DLG and ETGE to the Keap1 homodimer appears to 
lock Nrf2 in a position that promotes ubiquitin transfer (87). As the DLG motif is 
only weakly bound to Keap1, an alteration in the conformation of Keap1 may disrupt 
the Keap1-DLG association and thus impede the ubiquitination of Nrf2 (96). This has 
led to proposal of the “hinge and latch” model to illustrate how Keap1 represses Nrf2, 
where the ETGE motif is characterized as the hinge, and the DLG as the latch (96). 
This model suggests that when the DLG and ETGE motifs are bound to Keap1, the 
lysine residues of the Neh2 α-helix are maximally exposed for ubiquitination and 
Nrf2 is efficiently degraded. If one of the motifs dissociates from Keap1-DC 
however, the ubiquitination may not be optimized and the degradation of Nrf2 may 
be abrogated (96). 
Regulation of Nrf2 transactivation by cellular kinases 
Phosphorylation is important in regulation of gene expression in eukaryotic cells 
(58). Several transcription factors have been shown to undergo phosphorylation, 
including Nrf2 (97). Specific kinase signals may regulate the nuclear translocation of 
Nrf2, and its ability to induce EpRE-dependent transcription (97;98). 
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MAPKs 
MAPKs are serine/threonine kinases that convert various extra cellular signals into 
different phosphorylation cascades (99). Three MAPK signalling pathways have been 
identified; extracellular signal-regulated protein kinases (ERK), c-Jun N-terminal 
kinase (JNK) and p38 MAPK. They all consist of three subsequent kinases and work 
in the same way: a MAPK kinase kinase phosphorylates and activates a MAPK 
kinase, which phosphorylates and activates a MAPK that generally performs the 
ultimate task of the MAPK pathway. 
All three identified MAPKs have been found able to regulate EpRE-dependent 
transcription (100). JNK1 has been suggested to be an important upstream activator 
of Nrf2, since induction of EpRE-dependent transcription by a known inducer appear 
to depend on this MAPK (101). Another study showed that ERK2 may be involved in 
up-regulation of cytoprotective proteins mediated by tert-butylhydroquinone (tBHQ), 
a known inducer of EpRE-dependent transcription (102). For p38 MAPK, Keum et 
al. (100) showed that an over-expression of this kinase suppresses the constitutive as 
well as the induced EpRE-dependent gene transcription, while certain inducers of 
EpRE-dependent transcription have been suggested to act through activation of this 
kinase (103). Thus, while ERK2 and JNK1 MAPKs appear to be activators of EpRE-
dependent transcription, the effect of p38 MAPK on EpRE-dependent transcription 
remains debated (86). 
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PKC 
Protein kinase C (PKC) is a serine/threonine kinase that in response to inter- and 
intracellular signals phosphorylates proteins controlling cell growth and 
differentiation (99). A study showed that Nrf2 was activated and translocated to the 
nucleus by a known PKC activator, phorbol 12-myristate 13-acetate (PMA), while 
the translocation was abrogated by an inhibitor of PKC (97). Nrf2 was further shown 
to be phosphorylated by inducers of EpRE-dependent transcription as well as PKC 
activators, but not after pre-treatment with a PKC inhibitor. A following study 
showed that Nrf2 contains a serin-40 that is necessary for the observed Nrf2-
phosphorylation by PKC (104). As this is situated in the Neh2 domain of Nrf2, it is 
possible that phosphorylation of serin-40 abrogates the association between Nrf2 and 
Keap1 and allows Nrf2 to translocate to the nucleus. 
PI3K 
Phosphatidyl inositol-3 kinase (PI3K) is an important lipid kinase controlling cell 
growth, differentiation and apoptosis (99). The downstream targets of PI3K are 
phospholipase C (PLC) and serine threonine kinase Akt/protein kinase B (Akt/PKB) 
(105). An involvement of this kinase in EpRE activation has been suggested, and 
PI3K inhibitors have been shown to repress hemin-induced Nrf2 nuclear 
translocation and expression of cytoprotective proteins in human neuroblastoma cells 
(105). 
Inducers of EpRE-dependent transcription 
EpRE-dependent transcription has been shown to be induced by cellular stress 
(oxidants, electrophiles and shear stress), signalling molecules (nitric oxide, growth 
factors), oxidized lipids (15-deoxy-Δ12,14-prostaglandin J2, oxidized low-density 
lipoproteins), several synthetic compounds (e.g. BHQ), and also a wide range of 
components found in dietary plants (90;106-108). The inducers found in edible plants 
are of special interest since they can be supplied through the diet. A selection of 
dietary plant compounds found to induce EpRE-dependent transcription is presented 
in Table 1.7. 
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Table 1.7 A selection of EpRE inducers found in dietary plants (adapted from Surh (84))  
EpRE inducers found in edible plants 
Compound Example of source Experimental system Reference 
Cafestol, kahweol Coffee Nrf2-wild type 
C57BL/6 mice 
(109) 
Carnosol  Rosemary Rat kidney cell line  (110) 
Curcumin Turmeric Human hepatoma cells 
Swiss albino mice 
(103) 
(111) 
Diallyl sulfide Allium family of vegetables 
(onion, garlic, leek, shive, 
shallot) 
Nrf2-wild type 
C57BL/6 mice 
(112) 
Lycopene Tomato HepG2 cell line (113) 
Resveratrol Grape skin (and thus red 
wine), peanuts, berries (e.g. 
mulberry, blueberry, 
cranberry) 
Rat kidney cell line 
HepG2 cell line 
(114) 
(115) 
Sulphoraphane Cruciferous vegetables (e.g. 
broccoli) 
HepG2 cell line 
Nrf2-wild type mice 
(100) 
(116) 
Quercetin Apples, onions HepG2 cell line (117) 
Zerumbone Tropical ginger Rat liver epithelial cell 
line 
(118) 
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1.5 Health effects of combinations of dietary plants 
With identification of several bioactive compounds in food, a massive commercial 
industry has developed making supplements based on one or a few of these isolated 
compounds. However, although epidemiological studies indicate beneficial health 
effects of their plants of origin, individual phytochemical supplements studied do not 
appear to have consistent beneficial health effects (4;10;14). In fact, some studies 
have shown that high dose supplementation of single antioxidants may be harmful, 
and may even lead to increased cancer incidence among specific groups (4;119;120). 
It thus appears as the beneficial health effect of dietary plants not solely depends on 
one or a few bioactive components within these foods. 
Dietary plants contain thousands of phytochemicals with different size, structure, and 
mechanism of action (14). A meal composed of different plant sources will thus 
contain a large variety of phytochemicals. Supplements however, commonly only 
contain one or a few compounds, and thus in that way can not be compared directly 
with a phytochemical rich diet. Supplements furthermore lack components from the 
food matrix, such as macronutrients, vitamins, and minerals, which may be important 
contributors to the beneficial health effect of dietary plants (121). Administration of 
single dietary compounds may therefore be a major simplification of the actual 
biological impact of foods, and this could explain the apparent lack of beneficial 
health effects of phytochemical supplements. Research where whole foods, rather 
than individual food components is the variable is thus essential in nutrition research 
(121). 
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Food synergy 
Additive, synergistic and antagonistic effects are terms used in several scientific areas 
such as biology, chemistry and pharmacology (122). An additive effect defines a 
situation where the total effect of a combination of two or more agents is the same as 
the sum of the individual agents (Figure 1.7 C). A synergistic effect however, is 
when the total effect of the combination is greater than the sum of the individual 
agents (Figure 1.7 D), while an antagonistic effect defines a situation where the total 
effect of a combination of two or more agents is less than the sum of the individual 
agents (Figure 1.7 E). 
 
Figure 1.7 Presentation of additive, synergistic and antagonistic effects. A) Effect of compound 
A. B) Effect of compound B. C) Additive effect of combining A + B. D) Synergistic effect of 
combining A + B. E) Antagonistic effect of combining A + B. 
These terms may also be applied in nutrition research to describe the health effects of 
combined foods or food constituents (123). From epidemiological studies it is 
apparent that the dietary pattern has a great influence on health. It has therefore 
recently been hypothesized that the beneficial health effects observed for some 
dietary patterns, e.g. the Mediterranean diet, results from the combined effect of 
several components within the respective diet (124). Potential additive or synergistic 
effects of different food components may explain the apparent lack of health effect of 
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isolated compounds such as dietary antioxidants, and could contribute to a better 
understanding of the mechanisms behind the beneficial health effects of dietary plants 
(121). 
In a recent study investigating the effect of combinations of dietary plant extracts on 
NF-κB activity, several extract combinations were found to exert additive and 
synergistic effects on NF-κB inhibition (125). By showing that combinations of 
dietary plants may have additive and synergistic effects on molecular mechanisms 
such as NF-κB regulation, the results of this study supports the theories of food 
synergy. Few studies have however investigated the potential effects of dietary plants 
in combination on other signalling pathways, and it is therefore of interest to establish 
systems in which such combinations can be studied. 
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2. Aims of the thesis 
Up-regulation of cytoprotective proteins is assumed to be protective against several 
chronic pathological conditions. Cytoprotective proteins can be transcriptionally 
induced through a common element in their promoter called electrophile responsive 
element (EpRE). Several pure phytochemical compounds, as well as dietary plant 
extracts, have previously been shown to be effective inducers of EpRE-dependent 
transcription. Up-regulation of cytoprotective proteins may therefore partly explain 
the beneficial health effect of dietary plants. 
With the emerging interest on synergistic and additive effects among food 
components, studies investigating such effects on EpRE-dependent transcription are 
needed. This thesis focuses on the combinatorial effects of dietary plants on EpRE-
dependent transcription. Also, to expand the knowledge beyond in vitro induction of 
EpRE-dependent transcription, transgenic EpRE mice were utilized. 
The specific aims of this thesis are: 
• To study the dose-response effect on EpRE-dependent 
transcription by dietary plant extracts not previously tested in 
EpRE-LUC HepG2 cells. 
• To study the effect of combinations of dietary plant extracts on 
EpRE-dependent transcription in vitro. 
• To study the effect of one dietary plant extract on EpRE-
dependent transcription in vivo, using transgenic reporter mice. 
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3.  Materials 
3.1 Cell line 
Cell line Distributor Location 
 
HepG2 (HB-8065) The American Type Culture 
Collection 
Manassas, VA 
 
3.2 Cell culture materials  
Chemical/compound/ 
equipment 
Manufacturer Location 
Cell culture flask 75 cm2 BD Falcon, 353110 San Jose, CA 
Cell culture plates 12, 24 
wells 
Corning Inc. Corning, NY 
EpRE luciferase reporter 
plasmid 
  
Fetal Bovine Serum Sigma, F-7524 St. Louis, MO 
L-Glutamine Sigma, G-7513 St. Louis, MO 
Lipofectamine Invitrogen Corp. Carlsbad, CA 
MEM Non-essential Amino 
Acid solution (100x) 
Sigma, M-7145 St. Louis, MO 
Minimum Essential Medium 
Eagle 
Sigma, M-4526 St. Louis, MO 
Opti-mem Invitrogen Corp., 11058-
021 
Carlsbad, CA 
Penicillin/Streptomycin 
Solution 
Sigma, P-4458 St. Louis, MO 
Sodium pyruvate solution Sigma, S-8636 St. Louis, MO 
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3.3 Plasmid isolation 
Chemical/compound/ 
equipment 
Manufacturer Location 
Agar MERCK Dermstadt, Germany 
Ampicillin Sigma, A0166 St. Louis, MO 
Isopropanol  Arcus Kjemi AS Vestby, Norway 
Pepton MERCK Dermstadt, Germany 
Yeast extract MERCK Dermstadt, Germany 
Jetstar 2.0 Plasmid kits Genomed GmbH Löhne, Belgium 
NaCl MERCK Dermstadt, Germany 
 
3.4 Transgenic mice 
Transgenic mice Distributor Location 
EpRE-luciferase mice Cgen Oslo, Norway 
3.5 Materials for in vivo experiments 
Equipment Manufacturer Location 
Cameo 25 Gas Syringe Filter, 
0.22 micron? 
Osmonics Inc, DGA02025SO Minnetonka, MN 
Centrifuge tubes, 15 and 50 ml BD Biosciences Franklin Lakes, NJ 
Feeding tube for oral gavage 
feeding 
Agn Tho's AB 
 
Lidingö, Sweden 
Micro tubes 1.5 ml Sarstedt Nümbrecht, Germany 
Omnifix (syringes) 1 and 10 ml Braun Melsungen AG Melsungen, Germany 
Sterican (needles) 0.15x16 mm Braun Melsungen AG Melsungen, Germany 
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3.6 Chemicals 
Chemical/compound Manufacturer Location 
2,4,6-tripyridyl-s-triazine 
(TPTZ) 
Fluka Chemie AG Deisenhofen, Switzerland 
2-Propanol (HPLC – grade) Merck Darmstadt, Germany 
Acetic acid Merck Damstadt, Germany 
Albumin Bio-Rad Laboratories Inc., 
500-0007 
Hercules, CA 
Argon AGA, 100325 Oslo, Norway 
ATP (adenine triphosphate) Roche Diagnostics Ottweiler, Germany 
Bio-Rad Protein Assay Bio-Rad laboratories 
Inc.,500-0006 
Hercules, CA 
Coenzyme A Roche Diagnostics Ottweiler, Germany 
Corn oil Biochemica Sigma, C-8267 St. Louis, MO 
D-Luciferin Biosynth AG Staad, Switzerland 
DMSO 
(dimethylsulphoxide) 
Sigma, D-5879 St. Louis, MO 
DTT (dithiothreitol) Sigma St. Louis, MO 
EDTA (diethylenediamine 
tetra-acetic acid) 
Merck Darmstadt, Germany 
Ethanol Arcus AS Oslo, Norway 
FeCl3 • 6H20 BDH Laboratory Supplies Dorset, England 
FeSO4 • 7H2O Riedel-deHaën AG Seelze, Germany 
Hydrochloric acid Merck Darmstadt, Germany 
Isoflourane Baxter AS Oslo, Norway 
Methanol (HPLC-grade) Merck Darmstadt, Germany 
MgSO4 • 7H2O Merck Darmstadt, Germany 
MilliQ water Millipore Bedford, MA 
PBS (Phosphate buffered 
saline) 
Bio Whittaker, BE17-512F Verviers, Belgium 
Reporter Lysis Buffer Promega, E3971 Madison, WI 
Sodiumacetate trihydrate Riedel-deHaën AG Seelze, Germany 
Tricine Sigma, T5816 St. Louis, MO 
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3.7 Dietary plant extracts 
Name Latin Name/Commercial 
name 
Producer Location 
Broccoli (provided 
by Garmannvik 
Johansen) 
Brassica oleraceae var. 
italia 
Thor Graff ICA, Grünerløkka, 
Norway 
Coffee Coffea arabica Friele Bergen, Norway 
Cocoa (provided by 
Garmannvik 
Johansen) 
Freia Regia originalkakao Freia Kraft Foods Oslo, Norway 
Dog rose (provided 
by Kolberg) 
Rosa canina  Oslo, Norway 
Oregano Oreganum vulgare Hindu Bergen, Norway 
Red Onion Allium cepa Unknown 
producer 
Deli de Luca, Bislett, 
Norway 
Red Wine (provided 
by Garmannvik 
Johansen) 
Da Luca, Primitive Merlot 
Tarantino 
MGM Mondo del 
Vino 
Italy 
Rosemary (cells) Rosmarinus officinalis Santa Maria Mölndal, Sweden 
Rosemary (mice) Rosmarinus officinalis Hindu Bergen, Norway 
Thyme Thymus vulgaris Hindu Bergen, Norway 
Cherry tomato  Solanum, lycopersicum Henning Ruud ICA, Bislett, Norway 
Turmeric (provided 
by Kolberg) 
Curcuma longa Rajah Enfield, England 
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3.8 Instruments 
Instrument Manufacturer Location 
Biofuge Fresco Heraeus Instruments Osterode, Germany 
2510 Branson Branson Ultrasonics Corp. Dansbury, CT 
IVIS Imaging System 100 Series Xenogen Corporation Alameda, CA 
 
Labofuge 400e Heraeus Instruments Osterode, Germany 
Luminometer TD 20/20 Turner Designs Sunnydale, CA 
Megafuge 1.0 R Heraeus Sepatech GmbH Harz, Germany 
Nano Drop Spectrophotometer 
ND-1000 
Saveen Werner Limhamn, Sweden 
Synergy 2  Bio Tek® Instruments, Inc Winooski, VT 
Technicon RA 1000 system Technicon Instruments Corporation New York, NY 
Titertek Multiskan Plus ELFAB Finland 
Orbital Incubator Weiss Gallenkamp Leicestershire, 
England 
Avanti J-26 XP Beckmann Coulter Fullertone, CA 
 
3.9 Software 
Software Manufacturer Location 
 
Adobe Illustrator 10 Adobe Systems Incorporated San Jose, CA 
Gen 5TM PC Bio Tec® Instruments, Inc Winooski, VT 
Living Image Software Xenogen Corporation Alameda, CA 
Microsoft Office XP Microsoft Corporation Redmond, WA 
Reference manager 11 ISI Research Soft Carlsbad,CA 
SPSS 16 for Windows SPSS Inc. Chicago,IL 
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4. Methods 
4.1 Dietary plant extracts 
Spices, cherry tomatoes, coffee, and red onion were bought in local grocery stores in 
Oslo. The extracts of broccoli, cocoa, dog rose, red wine, and turmeric, were 
generously provided by previous masterstudents in Rune Blomhoffs group, Marit 
Kolberg and Siril Garmannvik Johansen. 
The foods were homogenized by a food processor, and 10 g of the products were 
measured out into tubes. For dry foods, 10 ml of methanol (MeOH) and 10 ml of 
MilliQ H2O (MQ-water) were added. For some products, like thyme, 20 ml of these 
solvents were needed to make a homogenous dilution of the material and the liquid. 
For vegetables, 10 ml of MeOH, and MQ-water depending on their water content was 
added; tomatoes contains 94 % water, and therefore 10 ml of MeOH and 10 ml – (10 
g x 0.94) = 0.6 ml MQ water was added. The tubes were vortexed for 30 seconds, and 
thereafter sonicated in a 0ºC water bath for 30 minutes. 
After sonication, the extracts were transferred into falcon tubes and then centrifuged 
at 4ºC and 4000 rpm for ten minutes. The supernatant was transferred into 
Erlenmeyer flasks, and to collect as much as possible of the liquid phase the 
centrifugation was repeated. The Erlenmeyer flasks were then placed under nitrogen 
gas, to evaporate all the alcohol and as much as possible of the water, concentrating 
the liquid to a viscid fluid at a total amount of < 4 ml. 
4.1.1 Extracts for cells 
For cell experiments, the concentrated extracts were diluted to a total amount of 5 ml 
with Phosphate Buffered Saline (PBS), or Dimethyl Sulfoxide (DMSO) + PBS if the 
content was difficult to dissolve in PBS alone. The final concentration of DMSO in 
cell culture never exceeded 0.2 ‰. The extracts were then sterile filtered with a 0.22 
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μm filter, transferred into airtight tubes and stored under argon at -70ºC. Final 
concentrations of the extracts were 2 g/ml. 
4.1.2 Extracts for animals 
For animal experiments the concentrated extract was diluted to a total amount of 5 ml 
with corn oil. The extract was transferred into airtight tubes, and stored under argon 
at -70ºC. Final concentration of the extract was 2 g/ml. 
4.2 Luciferase as a reporter system 
The regulation of a DNA sequence can be studied by linking the sequence to an 
easily detectable reporter gene, such as firefly luciferase. The firefly luciferase 
protein catalyzes bioluminescent oxidation of luciferin in the presence of ATP, 
magnesium and oxygen. This generates oxyluciferin and measurable luminescent 
light with a wavelength of 520-570 nm and peak density at 560 nm (126). The gene 
coding for firefly luciferase can therefore be used as a reporter gene, by inserting a 
reporter construct containing the luciferase gene into a genome and add luciferin to 
the system. If expressed, the luciferase will produce luminescent light by oxidation of 
the luciferin, and when luciferin and ATP are available in surplus the luminescence 
will be linear to the luciferase expression (126). The luminescence will signify the 
activity of the element that is attached to the luciferase reporter gene. 
 
To incorporate a gene of interest, e.g. reporter gene constructs, into a genome, 
plasmids can be used. A plasmid is an extra-chromosomal DNA molecule separate 
from the chromosomal DNA, capable of replicating independently from the 
chromosomal DNA. Plasmids usually occur naturally in bacteria, and are often 
circular and double-stranded. A previously described luciferase reporter plasmid 
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construct containing two EpRE sequences (127) was used in the experiments in this 
thesis to study the effect of different extracts on EpRE activity (Figure 4.1). 
 
Figure 4.1 Illustration of the luciferase gene coupled to a promoter containing two EpRE 
motifs. 
4.3 In vitro experiments 
4.3.1 Cell culturing  
Cell line 
The in vitro experiments in this project were carried out in HepG2 cells. The HepG2 
cell line is a human hepatocellular carcinoma cell line, isolated from a Caucasian 
male (128). 
Cell medium 
The cells were grown in Eagle’s Minimum Essential medium (MEM), supplemented 
with 10 % heat-inactivated fetal bovine serum, streptomycin (50 mg/ml), non-
essential amino acids (0.01 %), sodium-pyruvate (1 mM) and L-glutamin (2 mM). 
The medium was changed every 2 – 3 days. The cell cultures were contained in a 
humidified atmosphere with 5 % CO2 at 37ºC. Transient transfection was performed 
using cell culture medium without penicillin according to manufacturer’s instruction. 
Cell culturing 
The cells were split 1:3 – 1:5 when confluent, approximately twice a week and 
always the day before transfection. Cell viability and morphology was determined 
using a phase contrast microscope.  
 50 
When confluent, the old medium was removed, and the cell layer in the flasks was 
rinsed with 4 ml 0.25 % trypsin containing 0.02 % (w/v) EDTA to remove the bovine 
serum and any protease inhibitors from the cells. Then 3 ml of 0.25 % trypsin was 
added, and the cell flasks were placed in 37ºC for 5 – 10 minutes. When the cells 
were dispersed, 6 ml of complete growth medium was added to the solution and the 
cells were gently aspirated by pipetting. The cell suspension was transferred in 
appropriate aliquots to new 75cm2 cell flasks, depending on the confluence of the cell 
culture. 
Freezing and thawing 
Stocks of HepG2 cells were stored in liquid nitrogen in the presence of DMSO to 
prevent formation of ice crystals and lysis of cells during storage. The cells were 
thawed rapidly by gentle agitation in a 37ºC water bath and transferred into 75cm2 
cell flasks with 20 ml cell culture medium. Medium was changed after 24 h to 
remove the DMSO, and after about two weeks the cells had resume normal growth 
rate and were used for experiments. 
Muliplication and isolation of the EpRE-LUC plasmid 
The 2 x EpRE-LUC construct used in the experiments had been made previously and 
inserted into plasmids containing an ampicillin resistant gene (127). The plasmids, 
containing an ampicillin resistant gene, had been inserted into competent DH5α 
E.Coli bacteria by transformation. Bacteria reproduce rapidly, and each of the new 
bacteria contains one or more copies of the plasmid. 
To multiply the plasmid, glycerol stocks of plasmid containing bacteria were thawed 
and transferred to flasks containing 100 ml LB- medium supplemented with 50 μg/l 
ampicillin. The flasks were incubated over night at 37ºC in an orbital incubator, and 
then the E.Coli bacteria were then pelleted by centrifugation. To isolate the plasmid, a 
Jet Star Maxi preparation was performed, which employs a modified alkaline/SDS 
method to prepare a cleared lysate. After neutralization, the lysate was applied onto a 
Jet Star Column, where the plasmid is bound to an anion exchange resin. The resin 
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was washed to remove RNA and other impurities, and finally the plasmid was eluted 
from the column and concentrated by alcohol precipitation. The precipitated plasmids 
were dissolved in MQ-water and DNA concentration was quantified by a photometer 
prior to transfection of plasmids into HepG2 cells. 
4.3.2 Experimental outline 
Transfection  
The cells were cultured at approximately 60 % confluence the day prior to 
transfection, in 12-well cell culture plates (22 mm). For the dose-response 
relationship studies of extract combinations however, 24-well cell culture plates (11 
mm) were used. The plates were contained in a 37ºC incubator over the night, in 
order to let the cells attach to the wells and grow. 
The HepG2 cells were transiently transfected using Lipofectamin 2000, a cationic 
lipid-based transfection agent. According to the manufacturer’s protocol, each well of 
the 12-well cell culture plates was added 1.6 μg DNA diluted in 100 μl Opti-mem, 
and 2 μl Lipofectamin 2000 diluted in 100 μl Opti-mem. Each well of the 24-well 
cell culture plates was added 0.8 μg DNA diluted in 50 μl Opti-mem, and 1 μl 
Lipofectamin 2000 diluted in 50 μl Opti-mem. The dilution of Lipofectamin 
2000/Opti-mem was incubated in room temperature for 5 minutes before it was 
combined with the DNA/Opti-mem dilution, and the final mixture was incubated at 
room temperature for 20 minutes to allow the DNA-Lipofectamin 2000 complexes to 
form. Each well of the 12-well culture plates were added 800 μl of a culture medium 
without penicillin, and 200 μl of the DNA/Lipofectamin 2000 mix. Each well of the 
24-well culture plates were added 400 μl of the same culture medium, and 100 μl of 
the DNA/Lipofectamin 2000 mix. The cell-plates were placed in an incubation 
cabinet for 6 h to optimize the transfection, before the DNA/Lipofectamin 2000 mix 
was removed and replaced with 1000 μl complete culture medium. 
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Incubation with food extracts 
The following day, the cells were incubated with food extracts. The cell culture 
medium was replaced with fresh medium, and the cell wells were incubated with 
extracts in different concentrations or vehicle control for 17 h. A total amount of 15 
μl extract was added each well, diluted with PBS or PBS/DMSO (4:1) depending on 
the solvent used when making the extracts. As a control, PBS or PBS/DMSO (4:1) 
was added in the same amount as the extracts. 
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Figure 4.2 Extract stimulation of transiently transfected EpRE-LUC HepG2 cells. Extracts were 
administrated both separately and in combination. A) To study single extracts, three different 
concentrations of the extract were administrated in 12-well cell culture plates. B) To study the effect 
of extract combinations in 12-well cell culture plates, a single concentration of each extract was 
added individually and in combination. To study the effect of extract combinations in 24-well cell 
culture plates, several different concentrations of each extract were administrated individually (4.2 C) 
and in combination (4.2 D) on different cell plates. 
When testing single plant extracts in 12-well cell plates, three concentrations of the 
extract were used (Figure 4.2 A). To study the effect of a combination of two 
extracts, a single concentration of each extract was administrated individually and in 
combination (Figure 4.2 B). In the dose-response relationship studies of extract 
combinations however, 8 concentrations of each extract were administrated 
individually (Figure 4.2 C) and in combination (Figure 4.2 D). All cell plates were 
incubated at 37ºC for 17 h after extract stimulation. 
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Luciferase measurements 
After extract incubation, the luciferase activity was measured. Two different methods 
for luciferase measurement were applied. 
Effect of single plant extracts and extract combinations in 12-well cell plates 
The medium containing the extracts was removed, and each well was added 300 μl of 
lysis buffer. The cell plates were placed in 4ºC for 20 minutes to optimize cell lysis. 
After lysis the cells were collected by a cell scraper and transferred into eppendorf 
tubes, which were vigorously vortexed and then centrifuged at 4ºC for 5 minutes. An 
amount of the supernatant (20 μl) was transferred into luminometer tubes, and 100 μl 
Luciferase assay was added (see below). The firefly luciferase assay system contains 
ATP, luciferin, Mg2+, Coenzyme A (CoA) and a buffer that maintains a pH of 7.8 to 
optimize the luciferase bioluminescent reaction in lysed cells. The luciferase activity 
was measured in a TD 20/20 luminometer after 3 seconds of vortexing. 
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Luciferase assay solution 
Reagents Amount 
ATP (Adenosine triphosphate) 52,1 mg 
Coenzyme A (CoA) 20,7 mg 
Tricine 358,4 mg 
MgSO4 x 7 H2O 92,2 mg 
DTT (dithiothreitol) 513,5 mg 
EDTA (ethylenediaminetetraacetic 
acid) 
15 μl 
ddH2O 80 ml                               
+ Adjustment volume 
d-Luciferin (20 mg/ml) 650 μl 
Ingredients were mixed, pH adjusted to 7,4 by a pH meter, and ddH2O 
was added to a total volume of 100 ml. 
 
 
Effect of dose-response relationship of extract combinations in 24-well cell plates 
All wells were added 10 μl Luciferin, and incubated 5 minutes at 37 ºC before 
luminescence was measured in a Synergy 2 instrument. This is a computer controlled 
single-channel microplate reader, using BioTec’s Gen 5™ PC software. Gen 5 
reports the results of the measurements as Relative Luminescence Units (RLU), 
which is the average of data points in each well during the integration time (10 sec). 
Luciferin was given in excess so that the luciferase is the limiting factor of the 
reaction. 
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4.4 In vivo experiments 
4.4.1 Work in advance of the animal experiments 
The animals used in this thesis are bred and attended to at the Department of 
Comparative Medicine, Faculty of Medicine, University of Oslo. 
Animal research has had a vital role in many scientific and medical advances of the 
past century, such as in production of insulin, penicillin, antidepressive medicines, 
and several vaccines. However, the use of living animals in research raises essential 
ethical questions. It is therefore important that all experiments involving living 
animals are well considered and strictly planned, so that unnecessary use of animals 
in research is avoided. The mice used in this thesis were attended to as required by 
the guidelines of the Federation of European Laboratory Animal Science 
Associations (FELASA). All experiments were further performed according to the 
national guidelines for animal welfare. 
To provide for the best possible environment for the animals, the access to the animal 
department is severely restricted. This ensures that the people who handle the animals 
are well trained for this purpose, and that the appropriate ethic standards are being 
met. Thus, in order to get access permission, we made an agreement with the person 
in charge at the animal department to read curriculum on “laboratory animal science” 
before the project was started. We then received internal instructions in the routines 
and methods at the animal department by our co-supervisors Ingvild Paur and Trude 
Rakel Balstad. 
4.4.2 Transgenic reporter mice 
To study the effects of phytochemical rich extracts on EpRE activity in vivo, an 
experiment with transgenic reporter mice was performed. These mice have been 
developed by the research group, and contain the same EpRE luciferase construct as 
 57
used in the HepG2 cells were transiently transfected with (129). Transgenic reporter 
mice are generated by pro-nuclear micro-injection, injecting the reporter construct 
into one of the nuclei of a fertilized mouse zygote. This technique is further explained 
by Carlsen et al. (130). 
4.4.3 Experimental outline 
An in vivo experiment administrating rosemary extract was carried out on 4 different 
days, involving a total number of 14 male mice. At the first and second day of the 
experiment, the mice were followed for 24h after administration of the rosemary 
extract to measure the EpRE luciferase activity in the mice during this time (Figure 
4.3). These data was used to establish the time point with the largest difference in 
luciferase activity between the extract and control group, at which the mice were 
sacrificed at the third and fourth day of the experiment. The same 6 mice were used 
in the first three days of the experiment, although only four of these were included at 
the third day, and eight new mice were included at the fourth day. The mice were 
randomized into an extract or a control group, each group including the same number 
of mice. 
 
Figure 4.3 Experimental outline of the in vivo experiment 
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Prior to the start of the experiment, the mice were fasted for three hours. After the 
first in vivo imaging, the mice were tube fed with either 300 μl of a rosemary extract 
(extract group) or 300 μl corn oil (control group). In vivo imaging was performed at 
0, 2, 5, 10 and 24h in the first study, and at 0, 2 and 5h in the second study. 
After in vivo imaging at 5h in the first study, the mice were sacrificed. The organs 
were excised, and ex vivo imaging were performed on the liver, spleen, kidney, 
thymus, heart, lung, skin, muscle, intestine, testis, epididymis, adipose tissue and the 
brain. The organs, except for the intestine, were then transferred to separate tubes for 
storage at – 70 ºC for later analysis.  
4.4.4 In vivo and ex vivo imaging 
In vivo imaging was performed at the given time points in an IVIS 100 System. The 
mice were anesthetized using 2.5 % isofluoran, and shaved on the abdominal region 
before imaging. D-luciferin (160 mg/kg) was injected intraperitoneal, and mice were 
placed in a lightproof chamber where the isofluoran anaesthesia was maintained. 
Seven minutes after the injection of D-luciferin, the luminescence emitted from the 
mice was recorded for one minute or thirty seconds depending on the intensity of the 
luminescence. Ex vivo imaging was performed in the same way, utilizing the D-
luciferin that was injected before the last in vivo imaging. 
The luminescence in the images was quantified using Living Image Software. The 
luminescence captured by the in vivo imaging was quantified by placing circles 
around the abdomen of the mice, using the same sized circle in each picture of the 
same mouse. The ex vivo imaging was quantified by placing a circle or a square 
around the separate organs. The intestine was quantified by placing multiple circles 
and squares along the organ, measuring the luminescence of the large intestine and 
the small intestine separately to study whether there were any differences between the 
two sections. 
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4.4.5 Luciferase activity in tissues 
To compare the imaging with the luciferase activity of the organs, the organs were 
homogenized and the luciferase activity of the homogenates was measured by the 
luciferase assay. 
The organs were transferred into 5 ml tubes and added 1 ml of 1x Reporter Lysis 
Buffer (diluted with MQ-water from 5x Reporter Lysis Buffer). The brain and the 
liver however, were transferred into 10 ml tubes, and added 2 ml of Reporter Lysis 
Buffer. The tissue samples were kept on ice. The organs were homogenized by Ultra 
Thorax. The homogenates were transferred into Eppendorf tubes, and centrifuged for 
15 minutes at 13000 rpm and 4 ºC in a Biofuge. 
The supernatant was transferred into luminometertubes in duplicates of 20 μl. After 
addition of 100 μl of room-tempered Luciferase Assay Solution, the samples were 
vortexed for three seconds and the luminescence of the homogenates was measured 
by a TD 20/20 luminometer. 
4.4.6 Protein concentration of the tissues 
Since the tissue samples differ in size, the luciferase activity was adjusted for the 
protein content of the sample in order to compare the luciferase activity of the 
respective organs between the two groups. The protein concentration of the 
homogenates was measured by the Bradford protein assay. This colorimetric protein 
assay is a simple and accurate procedure of determining concentration of proteins, 
and relies on the binding of the dye Coomassie Brilliant Blue G-250 to aromatic 
amino acid residues of proteins. When binding to protein occurs, the absorbance 
maxima for an acidic solution of the dye shifts from 465 to 595 nm, and the colour of 
the dye changes from brown to blue. 
The supernatant of the tissue homogenates was diluted with MQ-water from 10 to 
200 times depending on the organs size and protein content. Solutions of known 
albumin concentrations were used as standards. Triplicates of each organ and 
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standards were added to a 96-well plate, 10 μl in each well. One well contained a 
blank of 10 μl MQ-water. Bio-Rad protein assay was diluted 1:4 in milliQ-water and 
filtrated through a paper before 200 μl was added to each well. The absorbance of the 
dye in each well was measured at 595 nm in a Titertek microplate reader, and the 
protein concentration was determined by relating the measurements to different 
albumin concentrations as a standard curve. 
 61
4.5 The Ferric Reducing Ability of Plasma (FRAP) assay 
The FRAP assay was performed to measure the reducing capacity of the extracts 
applied in this study. This method was originally developed by Benzie and Strain to 
detect the reducing capacity of biological fluids (131), but can also be performed on 
extracts of dietary plants (132). 
The FRAP method is based on the reduction of ferric iron (Fe3+) to ferrous iron 
(Fe2+). When occurring at low pH, reduction of ferric-tripyridyltriazine (Fe3+-TPTZ) 
to ferrous-tripyridyltriazine (Fe2+-TPTZ) develops an intense blue colour with an 
absorption maximum at 593 nm. This is a non-specific reaction, and all reductants 
with higher half reaction reduction potentials than Fe3+/Fe2+-TPTZ half reaction will 
drive the Fe3+-TPTZ reduction. Excess Fe3+-TPTZ is used, so that the limiting factor 
of the reaction, and colour formation, is the reducing ability of the sample. By 
measuring the light, one can detect the concentration of electron donating 
antioxidants in the sample (132). 
A Technicon RA 1000 system was applied to measure FRAP in the extracts. FRAP 
reagent (300 μl) was heated to 37ºC, and then added 10 μl of the samples. Each 
sample was measured in triplicates. The mixture of the sample and FRAP reagent was 
incubated for 4 minutes at 37ºC, and then the absorbance was measured at 600 nm. 
An aqueous solution with a known concentration of Fe2+ (1000 μmol/FeSO4 x 7H2O) 
was used to calibrate the FRAP assay. 
FRAP reagents 
 
Reagents Component Volume in FRAP 
Acetat buffer 300 mM acetate buffer, pH 3.6 + C2H4O2 16 
ml/l buffer solution 
25 ml 
HCl 40 mM 2.4 ml 
FeCl3  x 6 H2O 20 mM 2.5 ml 
TPTZ solution 250 mg in 5 ml methanol 155 μl 
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4.6 Statistical analysis 
All the statistical analysis was performed using SPSS 16.0, and the statistical 
significant difference was set to p< 0.05 for all the analysis. 
4.6.1 In vitro experiments 
A one way ANOVA was used to examine the effects of dietary plant extracts and 
their combination on luciferase activity in EpRE-LUC HepG2 cells. To identify 
differences, a Dunnett’s post hoc test was performed. In experiments studying 
separate extracts at different concentrations, the Dunnett’s post hoc test was used to 
compare the effect of the different extract concentrations to the control. While in 
experiments studying extract combinations, the Dunnett’s post hoc test was used to 
compare the individual extracts and the control to the extract combination. 
To examine the effect of the extract combinations, the observed effect of the 
combinations was compared to the expected effect (the sum of the effects of the two 
individual extracts) by a Student’s T-test. In the dose-response relationship studies of 
extract combinations, a Student’s T-test was also used to study the effect of the 
extract combinations to the average effect of the individual extracts at the same total 
amount of extract. 
4.6.2 In vivo experiments 
In order to examine the effect of the rosemary extract on EpRE-dependent luciferase 
activity in vivo, a non-parametric Mann-Whitney U test was employed to compare the 
extract and control groups. 
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5. Results 
5.1 Effect of dietary plant extracts on EpRE-activity in 
HepG2 cells 
5.1.1 Effect of dietary plant extracts on EpRE-dependent luciferase 
activity 
Several pure phytochemicals have been tested and shown to be effective inducers of 
EpRE mediated transcription in HepG2 cells transfected with EpRE-LUC reporter 
plasmid (129). A selection of extracts made of dietary plants high in at least one of 
these phytochemicals have been shown to induce EpRE mediated transcription as 
well. 
Three separate extracts which had not previously been tested for their ability to 
induce EpRE activity in HepG2 cells were tested in this thesis; namely, cherry 
tomato, cocoa, and red wine. These extracts were selected based on their high 
phytochemical contents: cherry tomato was selected due to its lycopene content; 
cocoa was selected due to its high flavonoid content; and red wine was selected due 
to its content of resveratrol. Each extract was tested in three concentrations; 3mg/ml, 
15 mg/ml and 30 mg/ml, and compared to a control of PBS. All of the experiments 
were repeated 2 - 3 times, and in each experiment, each treatment was performed in 
triplicates. 
Results are presented in Figure 5.1 as fold change as compared to the control. 
Figures display the mean ± the standard error of the mean (SEM). 
Of these three extracts only cocoa (Figure 5.1 C) gave a statistically significant 
increase in EpRE mediated luciferase activity compared to the control. For cocoa, 
there was a 1.92 ± 0.12 fold increase at 15 mg/ml (p= 0.02), with a further increase to 
2.60 ± 0.06 at 30 mg/ml (p < 0.01), as compared to the control. 
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Figure 5.1 Effect of food extracts on EpRE luciferase activity in HepG2 cells. EpRE LUC cells 
were incubated with the indicated concentrations of extracts for 17h, and the EpRE luciferase activity 
was measured in a luminometer. The effect of the different concentrations on EpRE-dependent 
luciferase activity was compared to a control of PBS (0 in the figure). The bars represent mean ± 
SEM (n = 3 for tomato, and n = 2 for red wine and cocoa). * = p < 0.05, ** = p < 0.01. A) Cherry 
tomato. B) Red wine. C) Cocoa. 
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5.1.2 Effect of combinations of dietary plant extracts on EpRE-
dependent luciferase activity 
To study the effect of combinations of dietary plant extracts on EpRE-dependent 
luciferase activity, two extracts were administrated individually and in combination 
to EpRE-LUC HepG2 cells. To evaluate the effect of the extract combinations, the 
EpRE-dependent luciferase activity of the extract combinations was compared to the 
sum of the effect of the individually added extracts. The measured luciferase activity 
of the extract combination is described as the “observed” effect, while the sum of the 
effect of the extracts added individually is described as the “expected” effect. An 
observed effect significantly higher or lower than the expected could indicate a 
synergistic or an antagonistic effect respectively. 
Based on previous experiments with dietary plant extracts in EpRE-LUC HepG2 cells 
(129), and the extracts tested separately in this thesis (Figure 5.1), eleven extract 
combinations were tested in this thesis (Table 5.1). The lowest extract concentrations 
observed to give a notable induction of EpRE-dependent luciferase activity in 
previous experiments were selected for the combinations. One exception from this 
was made, namely for red wine, as we wished to study the effect of a combination 
where one of the extracts did not have any inducing capacity on EpRE-dependent 
transcription when administrated individually. Rosemary, broccoli, turmeric, coffee, 
thyme, oregano, and red wine were tested at 3 mg/ml, while dog rose, red onion and 
cocoa were tested at 15 mg/ml. 
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Table 5.1 Extract combinations tested in the in vitro experiments 
Extract combinations tested 
Broccoli and rosemary 
Broccoli and turmeric 
Coffee and oregano 
Coffee and thyme 
Coffee and turmeric 
Dog rose and rosemary 
Dog rose and turmeric 
Red onion and rosemary 
Red onion and thyme 
Red wine and rosemary 
Rosemary and oregano 
 
All experiments were repeated at least three times, and in each experiment each 
treatment was performed in triplicates. The results are presented as mean fold change 
± SEM of EpRE-dependent luciferase activity compared to a PBS or PBS/DMSO 
control (Figure 5.2). Also listed are the expected and observed effects, the percent 
difference between these values, and the p-value of a comparison of these two values. 
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Figure 5.2 Effect of combination of plant extracts on EpRE-dependent luciferase activity. 
Transiently transfected EpRE-LUC HepG2 cells were stimulated with different extracts, individually 
and in combination. Their effect on EpRE-dependent luciferase activity was compared to a control of 
PBS or PBS/DMSO. The expected effect, i.e. the sum of the effect of the two extracts added 
individually, was compared to the observed effect of the extract combination. The bars represent 
mean EpRE luciferase activity ± SEM (n= 3 – 5). * = p < 0.05, ** = p < 0.01, *** = p < 0.001. The 
text box presents the expected and observed values of the combinations, their difference and the p-
values of their comparison. 
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A combination of coffee (3 mg/ml) and oregano (3 mg/ml) gave the highest induction 
of EpRE-dependent luciferase activity. The observed fold change was 15.84 ± 6.68, 
and significantly higher than the control (p< 0.05) (Figure 5.2 A). The observed 
effect was further 3.72 higher than the expected (30.7 % difference), however not 
statistically significantly different (p= 0.67). 
For the combination of red onion (15 mg/ml) and thyme (3 mg/ml) a fold change of 
9.86 ± 4.57 in EpRE-dependent luciferase activity was observed, however not 
statistically higher than the control (p= 0.14) (Figure 5.2 B). The observed luciferase 
activity of the combination was 0.93 higher than the expected (10.4 % difference), 
but not statistically significantly different (p= 0.88). 
With a fold change of 6.37 ± 1.20, the combination of rosemary (3 mg/ml) and 
broccoli (3 mg/ml) gave a statistically significant increase in luciferase activity 
compared to the control (p= 0.01), and rosemary administrated individually (p= 0.03) 
(Figure 5.2 C). The observed value was 0.23 higher than the expected value (3.7 % 
difference), but the two values were statistically significantly different (p= 0.93). 
The combination of broccoli (3 mg/ml) and turmeric (3 mg/ml) gave a fold induction 
of 4.88 ± 0.91 in the EpRE-dependent luciferase activity, which was statistically 
significantly higher than the control (p< 0.01), and the broccoli (p< 0.01) and 
turmeric (p< 0.01) extracts added individually (Figure 5.2 D). The observed value 
was 1.15 higher than the expected value (30.8 % difference), however not statistically 
significantly different (p= 0.31). 
With a fold change of 4.68 ± 1.65 in EpRE luciferase activity, the combination of dog 
rose (15 mg/ml) and rosemary (3 mg/ml) increased the EpRE-dependent luciferase 
activity significantly compared to the control (p= 0.02) and dog rose added 
individually (p= 0.02) (Figure 5.2 E). Despite an observed value 1.40 higher than the 
expected (42.7 % difference), the two values were not statistically significantly 
different (p= 0.42). 
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A combination of coffee (3 mg/ml) and thyme (3 mg/ml) (Figure 5.2 F) gave a fold 
change of 4.46 ± 1.00 in the EpRE-dependent luciferase activity, and the effect of the 
combination was significantly higher than the control (p= 0.01) and thyme added 
individually (p= 0.04). The expected value was further 0.17 higher than the observed 
value (4.0 % difference), but the two values were not statistically significantly 
different (p= 0.89). 
The combination of red onion (15 mg/ml) and rosemary (3 mg/ml) gave a fold 
induction in the luciferase activity of 4.12 ± 0.73, which was significantly higher than 
the control (p= 0.02) and the red onion extract administrated individually (p= 0.03) 
(Figure 5.2 G). With an observed value 0.09 higher than the expected value (2.2 % 
difference), the two values were not statistically significantly different (p= 0.94). 
A fold change of 4.05 ± 0.35 was observed for the EpRE-dependent luciferase 
activity for a combination of coffee (3 mg/ml) and turmeric (3 mg/ml). This was 
statistically higher than the control (p< 0.01), and the coffee (p= 0.02) and turmeric 
(p= 0.01) extracts added individually (Figure 5.2 H). The observed value was further 
0.12 higher than the expected value (3.1 % difference), but not statistically 
significantly different (p= 0.91). 
For a combination of dog rose (15 mg/ml) and turmeric (3 mg/ml), with a fold change 
of 2.46 ± 0.08 in the EpRE-dependent luciferase activity, the effect of the 
combination was statistically higher than the control (p< 0.01), and the dog rose (p< 
0.01) and turmeric (p= 0.01) extracts added individually (Figure 5.2 I). The observed 
effect was however 0.33 lower than the expected (11.8 % difference), but the 
expected and observed values were not statistically significantly different (p= 0.50). 
The observed fold change of 1.97 ± 0.45 for the combination of red wine (3 mg/ml) 
and rosemary (3 mg/ml) was not significantly higher than the control (p= 0.69) 
(Figure 5.2 J). The observed effect of the combination was further 0.97 lower 
observed than expected (33.0 % difference), however not statistically significantly 
different (p= 0.29). 
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The combination of rosemary (3 mg/ml) and oregano (3 mg/ml) had the lowest 
induction of EpRE-dependent luciferase activity, with a fold change of 1.57 ± 0.60, 
not statistically significantly different from the control (p= 0.71) (Figure 5.2 K). The 
observed value was 1.03 lower than the expected value (35.5 % difference), although 
not statistically significantly different (p= 0.80). 
Dose-response relationships of extract combinations 
In the first experiments studying the effect of dietary plant extracts in combination, a 
single concentration of each extract was administrated. To further understand the 
relationships between the single extracts and their combinations, experiments with a 
wider range of concentrations were performed. Based on the previous results showing 
a strong induction of EpRE luciferase activity by the combination of coffee and 
oregano, and a difference in expected and observed value of 3.72 in fold change (30.7 
% difference), this extract combination was selected for the extended study. The 
experiment was repeated three times, and in each experiment each treatment was 
performed in triplicates. The EpRE-dependent luciferase activity of the different 
treatments was compared to a control of PBS. 
The results are presented as mean fold change of the EpRE-dependent luciferase 
activity ± SEM (n= 3 for all concentrations except n= 2 for 6 mg/ml) (Figure 5.3). 
The figure shows a comparison of the extracts added separately and together in 
different concentrations.
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Figure 5.3 Effect on EpRE luciferase activity of coffee and oregano extracts. Transiently 
transfected EpRE-LUC HepG2 cells were stimulated with the indicated concentrations of coffee and 
oregano extracts, individually and in combination. EpRE luciferase activity was measured to 
compare the effect of the extract combinations with the separate extracts. The bars represent mean ± 
SEM (n= 3 for all concentrations except for n= 2 at 6 mg/ml). * = p< 0.05, ** = p< 0.01. 
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For the combination of 1 + 1 mg/ml of the two extracts, the observed fold change of 
EpRE-dependent luciferase activity was 3.07 ± 0.45. This was significantly higher 
than the control (p= 0.049), but not significantly higher than any of the two separately 
added extracts at 1 mg/ml (Figure 5.3 A). When comparing the observed and 
expected value of the combination, the observed value was significantly lower than 
the expected value at 5.00 ± 0.09 (p= 0.01). Secondly we compared the effect of the 
combination to that of the individual extracts at the same total concentration of food 
(1 + 1 mg/ml in the combination towards 2 mg/ml of the individual extracts). The 
average value of 2 mg/ml coffee and oregano was 2.90 ± 0.56, and thus somewhat 
lower than the combination of 1 + 1 mg/ml of the extracts, although not significantly 
different (p= 0.83). 
With a fold change of 3.96 ± 0.55, the combination of 2 + 2 mg/ml of the two extracts 
gave a statistically significant induction of the EpRE-dependent luciferase activity 
compared to the control (p< 0.01) (Figure 5.3 B). A statistically significant induction 
of EpRE was also observed for coffee at 4 mg/ml (p< 0.01), with a fold change of 
4.94 ± 0.40 compared to the control. When comparing the extract combination with 
the separate extracts at 2 mg/ml, their average value at 4 mg/ml (3.46 ± 0.46), or the 
expected value (6.30 ± 0.89), no statistically significant differences were found. 
For the results displayed in Figure 5.3 C, both 3 mg/ml and 6 mg/ml of coffee gave a 
statistically significant induction of EpRE compared to the control, with a mean fold 
change of 4.40 ± 0.70 (p= 0.01) for 3 mg/ml and (3.52 ± 1.24) (p= 0.01) for 6 mg/ml.  
For the extract combination of 3 + 3 mg/ml a fold change of 2.88 ± 0.39 was 
observed, while the expected value at this concentration was 7.24 ± 1.20 and nearly 
significantly different from the observed (p= 0.06). The average EpRE induction of 6 
mg/ml coffee and oregano extract was further higher than the observed value for the 
combination, however not statistically significantly different (p= 0.59). 
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5.2 Effect of dietary plant extracts on transgenic EpRE 
LUC reporter mice 
To investigate the effect of a dietary plant extract on the EpRE activity in vivo, 
experiments were performed using transgenic EpRE-LUC reporter mice. Previous 
studies have found a strong induction of EpRE-dependent activity in vitro by 
carnosol from rosemary, as well as rosemary extract (110;129). An extract of 
rosemary was also found to induce EpRE-dependent luciferase activity in the in vitro 
studies of this thesis, although not statistically different probably due to a low extract 
concentration and thus a relatively low luciferase induction. Carnosol has further 
been found to be an exceptionally strong inducer of EpRE-dependent activity in vivo 
(129), and an extract of rosemary was therefore selected to study the effect of a 
dietary plant extract on EpRE-dependent activity in vivo. 
5.2.1 In vivo imaging 
In vivo imaging was performed at 0, 2, 5, 10 and 24h after gavage feeding. For 0 - 5h 
12 mice are included in each group, while for 5 - 24h 3 mice are included in each 
group (Figure 5.4). 
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Figure 5.4 In vivo imaging of EpRE luciferase activity after administration of rosemary extract. 
EpRE LUC mice were gavage fed with rosemary extract or corn oil (control), and in vivo imaging of 
the EpRE luciferase activity was performed after 0, 2, 5, 10 and 24 h (n= 12 for 0 – 5h, n= 3 for 5 – 
24h). Luciferase imaging is measured in photons/sec/cm2/steradian. * = P < 0.05. A) Comparison of 
the in vivo imaging of a mouse from each of the two groups. B) Fold change of EpRE-dependent 
luciferase activity 0 – 24h after gavage feeding. C) Box plot of the area under curve (AUC) for the 
average luciferase radiance 0 – 5h. D) Box plot of the AUC for the average luciferase radiance 0 – 
24h. 
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Figure 5.4 A displays a comparison of the in vivo imaging 0 – 5h after gavage 
feeding with either corn oil (control) or rosemary extract. With a mean luciferase 
activity measured at the start of the experiment at 700591 ± 63666 p/s/cm2/steradian 
for the control group, and 695616 ± 76814 p/s/cm2/steradian for the extract group, 
the two groups were not significantly different (p= 0.89). 
To measure the response to the rosemary extract, fold change of the luciferase 
activity from the base line value was calculated for the two groups at each time point 
(Figure 5.4 B). Although the luciferase activity was decreased in both groups during 
the experimental period, the extract group seemed to retain a higher luciferase 
activity than the control group. The largest difference between the luciferase activities 
of the two groups was seen at 5h, with a fold change compared to the base line value 
of 0.65 ± 0.06 for the control group and 0.88 ± 0.09 for the extract group, and at this 
time point the fold change values of the two groups were significantly different (p< 
0.05). The fold change values were however not statistically significantly different 
between the two groups at any of the other time points. 
To display the total response in EpRE-dependent luciferase activity of the two 
groups, the area under curve (AUC) for the average radiance (p/s/cm2/sr) is presented 
(Figure 5.4 C + D). The mean AUC of the imaging performed 0 – 5h was 2.81 x 106 
± 2.54 x 105 for the control group and 2.98 x 106 ± 2.31 x 105 for the extract group 
(Figure 5.4 C), not statistically different (p= 0.20). The mean AUC for the imaging 
performed 0 – 24h was further 2.57 x 107 ± 1.43 x 106 for the control group, and 2.97 
x 107 ± 1.97 x 106 for the extract group, however not statistically different (p= 0.71). 
5.2.2 Ex vivo imaging 
The time point with the largest difference in EpRE-dependent luciferase activity of 
the two groups after gavage feeding was decided from the in vivo imaging (Figure 
5.4 B). The last two experimental days, the mice were sacrificed at this time point to 
do ex vivo imaging and further analysis of the organs (Figure 5.5). The luminescence 
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was measured in photons/sec/cm2/steradian, and the mean fold change of the control 
group is set to one. 
 
Figure 6.5 Ex vivo imaging of the intestine after administration of rosemary extract. The mice 
were gavage fed with either corn oil (control) or rosemary extract, and after 5h the mice were 
sacrificed and the organs excised. The luciferase activity was measured by ex vivo imaging in 
photons/sec/cm2/steradian. The bars represent mean ± SEM (n= 6 in each group). A) Ex vivo imaging 
of the intestine in the control and extract group. B) Luciferase activity of the large and small 
intestines of the two groups. 
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Figure 5.5 A presents the ex vivo imaging of the intestines in the control and extract 
group at 5 h after gavage feeding. For the extract group, a fold change of 1.12 ± 0.14 
was observed in the luciferase activity of the large intestine, while a fold change of 
1.30 ± 0.18 was observed in the luciferase activity of the small intestine (Figure 5.5 
B). The luciferase activities were however not statistically different between the two 
groups in the large intestine (p= 0.59) or the small intestine (p= 0.31). 
5.2.3 Luciferase activity in tissues 
In addition to the luminescence measured ex vivo in the IVIS system, the luciferase 
activity was also measured by a luminometer in homogenates of the organs. To adjust 
for the size of the tissue samples, the measured luciferase activity was corrected for 
the protein content of the sample. 
 
Figure 6.6. Luciferase activity in various organs after gavage feeding with rosemary extract. 
The organs were excised 5h after gavage feeding with either extract or corn oil (control). The EpRE 
activity in homogenates of the organs was measured and corrected for total protein content. The bars 
represent mean ± SEM. n = 6 in each group. 
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The organs with the largest difference between the two groups were the brain, 
adipose tissue, thymus and heart (Figure 5.6). For the extract group, the fold change 
of luciferase activity was 1.36 ± 0.15 in the brain, 0.53 ± 0.07 in the adipose tissue, 
0.48 ± 0.13 in the thymus, and 1.44 ± 0.18 in the heart, as compared to the control 
group. The luciferase activities were however not statistically different between the 
two groups in any of the organs. 
5.3 FRAP analysis 
As an evaluation of the amount of potentially bioactive compounds present in the 
food extracts, FRAP assay was used to assess their total reducing capacity. The 
results are presented as mmol/100g of the original product (mean ± SD). 
5.3.1 FRAP analysis of food extracts used in cell experiments 
Eleven extracts were used in the in vitro experiments of this thesis, and their FRAP-
values are listed in Table 5.2. The oregano extract had the highest FRAP value, with 
78.25 ± 0.52 mmol/100g. The lowest reducing ability was measured in the broccoli 
extract, with a FRAP value of 0.77 ± 0.01 mmol/100 g. 
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Table 5.2 FRAP values of food extracts used in the in vitro experiments. *= extract and FRAP 
value was provided by Marit Kolberg and Siril Garmannvik Johansen. 
 
 
Extract FRAP (mmol/100 g) 
Mean (n=3) 
SD (mmol/100 g) 
Oregano  78.25 0.52 
Dog rose * 74.8 7.40 
Thyme 46.83 0.24 
Rosemary 30.82 0.93 
Coffee 19.35 0.81 
Cocoa * 8.48 0.61 
Cherry tomato 4.02 0.01 
Red wine * 3.37 0.06 
Red Onion 2.57 0.09 
Turmeric * 1.30 0.40 
Broccoli * 0.77 0.01 
 
5.3.2 FRAP analysis of extracts used in animal experiments 
One extract of rosemary was used in the in vivo experiments, and the FRAP value is 
presented in Table 5.3. 
Table 5.3 FRAP value of the rosemary extract used in the in vivo experiments  
 
Extract FRAP (mmol/100 g) 
Mean (n=3) 
SD (mmol/100 g) 
Rosemary 60.30 0.43 
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6. Discussion 
6.1 Discussion of methods 
6.1.1 Luciferase as a reporter system 
Reporter genes have become a valuable tool in studies of gene expression. The 
luciferase reporter system can be used to study the activation of promoters or 
promoter regions both in vitro and in vivo, and was utilized to determine the activity 
of EpRE-dependent transcription in this thesis. 
The advantage of the luciferase reporter is the high sensitivity due to low background 
luminescence, making it possible to detect low levels of gene expression. When 
luciferin is given in excess, there is a good correlation between the expressed 
luciferase and the intensity of luminescence. The translation of luciferase is very 
rapid, with maximum activity short time after initiation of transcription, and the 
enzyme has a relatively short half-life of about 2h due to high turn-over rate (133). 
The luciferase reporter system may therefore be a good detector of dynamic changes 
in EpRE-dependent transcription compared to alternative reporter genes, such as β-
galactosidase and green fluorescent protein, which do not have these advantages 
(134). 
As alternative methods to study activation of the Nrf2/EpRE pathway, electrophoretic 
mobility shift assay (EMSA) could be used to detect the interaction of Nrf2 and 
EpRE, while a TransAM™ Nrf2 assay could be used to detect activation of Nrf2. 
Such methods do however not report whether EpRE-dependent transcription is 
activated or not. The luciferase reporter system signifies the transcriptional activity of 
a specific promoter element, and therefore provides a well suited method to study the 
effect of dietary plants on EpRE-dependent transcription. 
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Use of the luciferase reporter gene in vivo 
By molecular imaging of the luciferase activity in transgenic EpRE-LUC mice, it is 
possible to study the activity of EpRE-dependent transcription in a living animal over 
time. Molecular imaging thus represents an interesting way to study the effect of 
dietary plants on EpRE-dependent transcription in vivo. 
Molecular imaging further allows non-invasive treatment of animals. It is possible to 
perform several measurements of the EpRE activity in the same animal, and the 
animal can thus serve as its own control. The number of animals needed in an 
experiment is reduced, and the effect of differences between the animals is lowered. 
The luminescence detected by molecular imaging is emitted from several tissues and 
organs within the mice. Since mammalian tissues can scatter and absorb photons, the 
detected luminescence may be different from the actual light emitted (130). 
Haemoglobin for example, absorbs light at wavelength range 450 - 570 nm, which 
includes the wavelength of the luciferase luminescence (130). Organs rich in blood, 
such as the liver, heart, spleen and kidney, may thus emit a lower proportion of its 
produced luminescence as compared to organs such as thymus and lungs. Therefore, 
to study the organs individually, the mice were sacrificed and the organs excised, 
imaged ex vivo, and homogenized for further luciferase analysis. 
6.1.2 In vitro studies 
Since it is easy to control the factors of influence in cell cultures, they are well suited 
for mechanistic studies. In vitro studies are further a non-invasive way to perform 
experiments, and the ethical dilemmas around most in vitro studies are generally 
minimal.  
Conclusions from in vitro studies can however not be directly transferred to intact 
organisms. While the cell culture conditions of HepG2 cells are very stable and 
controlled, the hepatocytes in the liver are under varying influence of different 
signalling molecules, nutrients, and hormones. In cell cultures, extracts are further 
added directly to the cells and not processed in the intestine. The compounds that 
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reach the cells in an in vitro experiment may therefore not be exactly the same 
compounds as those that would reach the corresponding cell type in vivo. In vitro 
studies are however of major importance to perform mechanistic studies, as well as 
screening studies of the effect of different treatments on molecular mechanisms; such 
as the effect of dietary plant extracts on EpRE-dependent transcription. 
Use of HepG2 cells  
The HepG2 cell line used in the in vitro experiments of this thesis is derived from a 
human hepatocarcinoma (128). Because of its characteristic as a cancer cell line it is 
capable of multiple replications in culture, and has a relatively long life compared to 
primary hepatocytes (135). The morphological characteristics and epithelial cell 
shape of HepG2 is compatible with those of liver parenchyma cells. The liver plays a 
major role in human metabolism, and is central for metabolism and function of the 
phytochemicals. The liver is further one of the main sites for phase I and II 
metabolism (12), and the HepG2 cell line has maintained many of the specialized 
functions that characterize normal human hepatocytes (136). The HepG2 cell line is 
therefore a good model for studies on the biological effects of phytochemicals (127), 
and may be particularly suited for studies on regulation of EpRE-dependent 
transcription. 
HepG2 is an adherent cell line, and the cell viability and morphology can be 
determined by a phase microscope. Cells viability was closely followed with respect 
to confluence, growth, detachment, and infections. Cells viability and potential 
cytotoxicity of treatments can be further studied by measuring the metabolic activity 
of the cells (e.g. incubating the cells with a tetrazolium salt that is cleaved into a 
measurable product by metabolic active cells), or by measuring the cells membrane 
integrity (e.g. by adding trypane blue that selectively colour dead cells, or by 
evaluation of the amount lactate dehydrogenase in the cell medium) (137). Some of 
these methods may however be unsuited to determine the HepG2 cell viability in this 
thesis. As several of the plant extracts contain reducing compounds; the ability of 
some of the methods to report cell viability would have been influenced (e.g. lactate 
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dehydrogenase). Studies on antiproliferative and cytotoxic effect of resveratrol, 
epicatechin, and phytochemicals derived from apples, have shown that the 
concentrations of treatment and the time-course necessary for cytotoxicity of 
phytochemicals in HepG2 cells is higher and longer than the concentrations and 
incubation-time used in this experiment (138-140). 
Experimental outline 
Transfection enables introduction of an experimental DNA element such as a reporter 
gene construct, into a cell line. In this study HepG2 cells were transiently transfected 
with a 2 x EpRE LUC plasmid construct. The Lipofectamine 2000 transfection 
reagent contains liposomes of cationic and neutral lipids, which can interact 
electrostatically with nuclear acids and merge with cell membranes to deposit their 
cargo inside (141). The efficiency of the transfection depends on the cell density, the 
cell passage, the amount of DNA:Lipofectamine 2000, and the incubation time of the 
Lipofectamin 2000 and DNA:Lipofectamine 2000 (141). It is possible to co-transfect 
a second reporter vector or protein as an internal control of the transfection 
efficiency, e.g. renilla luciferase, green fluorescent protein, or β-galactosidase (142). 
As transient transfection of HepG2 cells by the Lipofectamine 2000 is well 
established in our laboratory (127), such co-transfections were however not 
performed in the experiments of this thesis. The luciferase activity in stimulated cells 
was further always compared to a control. 
The cells were stimulated with plant extracts and incubated at 37ºC for 17h, due to 
previous experiments showing a maximal EpRE-dependent luciferase activity after 
17h of extract incubation (129). To study the effect of combinations of dietary plant 
extracts on EpRE activity in HepG2 cells, extracts were incubated both individually 
and in combination to the cells. In the first experiments with extract combinations, 
the luciferase activity was measured in a TD 20/20 luminometer using the luciferase 
assay system after cell lysis. This is a well established method used to measure 
luciferase activity in HepG2 cells in our laboratory, and has been used in several 
previous experiments with dietary plant extracts (127;129).  
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When combining the two extracts the final concentration of extract (not taking into 
account the type of extract) is higher than in each of the two concentrations alone. 
We can therefore not rule out the possibility that the effect of the extract combination 
is due to a higher amount of extract (higher “food count”), or whether the effect is 
dose-dependent. We therefore wished to examine a wider range of concentrations in 
each experiment, and a new experimental setup was planned. 
In this new setup, a new method to measure luciferase activity was used. In this 
method luciferin was added directly to the cell culture medium, and a Synergy 2 
luminescence plate reader was used to measure luciferase activity. This method has 
been used by the research group to measure the luciferase activity in U-937 3xκB-
LUC cells, but has not previously been used to measure the EpRE-luciferase activity 
in HepG2 cells. To verify the new method against the previously used, two 
identically experiments were performed with the two methods and they were found to 
correspond well (data not shown).  
6.1.3 In vivo experiments 
A cell line should consist of only one type of cells, and the physiological interactions 
occurring within an intact animal can not be imitated by these. EpRE activity may be 
influenced by several intracellular and extracellular factors, and the regulation of 
EpRE may be far more complex in an intact animal than in a single cell line. In vivo 
studies are therefore an important tool in nutritional and pharmacological research to 
study how EpRE activity can be affected in vivo. 
Transgenic reporter mice have offered a valuable opportunity to study in vivo 
regulation of genetic transcription. Compared with in vitro cell culture experiments, 
transgenic EpRE mice provide a unique possibility to study the EpRE activity at the 
whole body level, reflecting the dynamics of the complex biological networks. 
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6.1.4 Food extracts 
To extract as much as possible of these bioactive compounds from dietary plants, the 
extraction method should be able to extract polar as well as non-polar compounds. 
The extraction procedure used in this thesis was based on the method developed for 
FRAP analysis by Benzie and Strain (131), which has been modified by Halvorsen et 
al. (132) to include water and methanol as solvents. The method was further 
developed with evaporation of the liquid to concentrate the extracts for in vitro and in 
vivo experiments. 
Since the extraction method employs both water and methanol as solvents, it will be 
able to extract both hydrophilic and hydrophobic substances. The composition of the 
compounds being extracted is however not known. To characterize the profile of the 
compounds, procedures like high performance liquid chromatography (HPLC) (143) 
and liquid chromatography mass spectroscopy (144) could be performed. 
6.1.5 FRAP assay 
The reducing capacity of the extracts used in this study was measured by the FRAP 
assay. The FRAP assay measures the capacity of present antioxidants in a sample to 
reduce Fe3+ to Fe2+, and is therefore a direct measure of antioxidants or reductants. 
Other methods used to assess the antioxidant capacity are the 6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid (Trolox) equivalent antioxidant capacity 
(TEAC) assay, and the oxygen radical absorbance capacity (ORAC) assay. These 
methods are however based on the ability of antioxidants to neutralize reactive 
species generated in the sample mixture, and may thus be more indirect than the 
FRAP method. The results from TEAC and ORAC may further depend on the 
reactive species used, and the FRAP assay therefore provides a good measurement of 
the concentration of reductants in a sample (132). 
The FRAP assay gives fast and reproducible results, which are linear over a wide 
range of concentrations (131). The FRAP assay has further been found to correlate 
well with the total phenolic content of different samples (145;146). However, one 
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possible limitation of the FRAP assay is the low reactivity of thiols with ferric ions, 
due to lower reduction potential of thiols than the Fe3+/Fe2+-TPTZ half reaction. Few 
antioxidant thiols are nonetheless present in dietary plants, and the FRAP assay is 
therefore assumed to be a well suited method to measure the total antioxidant 
capacity of plants (132). 
In accordance with earlier studies (125;147), the highest FRAP values measured in 
this thesis were for the spices and coffee, with oregano reaching the highest value. 
For the other extracts, the FRAP values were also found to be in relatively good 
accordance with previous studies (125;147;148). For cherry tomatoes and red onion 
however, previous studies have published a FRAP value of 0.62 mmol/100g for 
cherry tomatoes (149), and 0.69 mmol/100g for red onion, respectively (132). The 
FRAP values obtained for the cherry tomato and red onions extracts in this thesis are 
thus much higher than previously measured. 
The differences seen in the FRAP values measured for the same plant species may be 
due to differences in species, manufacturer, land of origin, place of growing, and time 
of harvesting. This may lead to large variety in the composition of phytochemicals, 
and thus their reducing capacity. In tomatoes for example, the phytochemical 
distribution and amount of antioxidants is highly dependent on the conditions during 
cultivation (150). As the extracts are prepared by an extended extraction method 
compared to that used for the FRAP measurements on the foods, this is probably the 
largest source of variation in the FRAP values. 
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6.2 General discussion 
Epidemiological studies have showed an inverse relationship between consumption 
of dietary plants and the incidence of several chronic diseases, such as cancer, 
cardiovascular disease and diabetes (2;40). Therefore, with the high global burden of 
chronic diseases, research on the molecular mechanisms underlying the beneficial 
health effect of dietary plants should be highly prioritized. 
Dietary plants contain a wide range of phytochemicals. Several phytochemicals have 
been shown to induce cytoprotective proteins through the EpRE motif (84), and this 
induction has been suggested to contribute to the disease preventive effects afforded 
by dietary plants (62). Phytochemicals have further been suggested to work in an 
additive and synergistic manner, and the concept of synergy among phytochemicals 
has been postulated as important for the beneficial health effect of a diet high in 
dietary plants (14). 
Because of the link between induction of EpRE-dependent transcription and up-
regulation of cytoprotective proteins (75;76), cell lines and animal models with EpRE 
reporter constructs can be utilized to study the cytoprotective and chemopreventive 
potential of dietary plants. Several dietary phytochemicals, and a selection of dietary 
plant extracts high in at least one of these, have been studied and found to be potent 
inducers of EpRE-dependent transcription (84;129). Few studies have however 
investigated the effect of combinations of dietary plant extracts on EpRE-dependent 
transcription. Thus the main purpose of this study was to investigate and compare the 
individual versus the combined effect of dietary plant extracts on EpRE- dependent 
transcription. An in vivo experiment was also performed to study the ability of a 
dietary plant extract to induce EpRE-dependent transcription in living animals. 
The in vitro experiments showed that combinations of dietary plant extracts are 
potent inducers of EpRE-dependent transcription. Of the 11 extract combinations 
studied, 8 gave a statistically increased EpRE-dependent luciferase activity compared 
to the control, and 7 of these were further statistically higher than one or both of the 
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individually administrated extracts. There appear to be additive effects of several of 
the combinations. Three combinations however, showed a trend towards synergistic 
effects (rosemary + dog rose, broccoli + turmeric and coffee + oregano), while two 
other combinations showed a trend towards antagonistic effects (rosemary + oregano 
and red wine + rosemary). When a combination of oregano and coffee was tested in a 
wider range of concentrations, antagonistic effects were indicated at some of the 
concentrations. Furthermore, transgenic EpRE mice given rosemary extract had a 
significantly higher EpRE-dependent luciferase activity compared to control mice 5h 
after administration of the extract. In particular, the EpRE-dependent luciferase 
activity was higher in the intestine, kidney, heart and brain of the mice receiving 
rosemary extract, although not statistically significantly different. Thus, dietary plant 
extracts known as in vitro inducers of EpRE-dependent transcription may also induce 
EpRE-dependent transcription in vivo. 
6.2.1 Effect of dietary plant extracts on EpRE-dependent luciferase 
activity in vitro 
Tomato, red wine and cocoa extracts 
Tomato, red wine and cocoa extracts, not previously tested for their ability to induce 
EpRE in EpRE-LUC HepG2 cells, were studied in this thesis. Although lycopene and 
resveratrol, found in tomatoes and red wine, have been found to induce EpRE-
dependent transcription and up-regulate cytoprotective proteins in HepG2 cells as 
well as other cell lines (113-115;129), only the cocoa extract gave a significant 
induction of EpRE-dependent luciferase activity in this thesis. 
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Effect on EpRE-dependent transcription by combinations of dietary 
plant extracts 
The results of the extract combinations are summarized in Figure 6.1. The 
combinations of coffee + oregano, red onion + thyme and rosemary + broccoli gave 
the highest increase in EpRE activity. The induction of EpRE-dependent luciferase 
activity observed for the different extracts are in accordance with previous studies 
conducted by Balstad et al., who showed a relatively high fold change of luciferase 
activity in EpRE-LUC HepG2 cells at 3 mg/ml of coffee (fold change 3.8), oregano 
(fold change 4.1), thyme (fold change 8.8), and broccoli (fold change 4.0) (129). 
Coffee has also been shown to induce EpRE-dependent transcription in transgenic 
EpRE-LUC mice (151). 
 
Figure 6.1 Summary of the effect of extract combinations on EpRE-dependent luciferase 
activity. Eleven extract combinations were administrated to EpRE-LUC HepG2 cells, and their 
respective induction of EpRE-dependent transcription was measured by their luciferase activity. The 
bars represent mean ± SEM (n= 3 – 5). 
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As food synergy may have an important role in the beneficial health effect of dietary 
plants, it is of great interest to establish systems to study the combinational effects of 
dietary plants. In this thesis we compared the observed effect of the extract 
combinations to the sum of the individually administrated extracts. This was done to 
study whether the actual effect of the combination was equal, larger or smaller than 
the sum of the effect of the individual extracts. As there were no statistically 
significant differences between the expected and observed values, no observed effects 
were significantly higher or lower than the expected value. Several of the 
combinations had a relatively low difference between the expected and observed 
value; while a total of 6 combinations had a difference < 12 %. This indicates that 
there may be additive effects of several of the extract combinations tested in this 
thesis. Additive effects of dietary plants on EpRE-dependent transcription may 
contribute to the understanding of the health benefits of a diet rich in dietary plants. 
Some of the differences between the expected and observed values of the extract 
combinations were however noteworthy. For 3 combinations the observed effect was 
> 30 % higher than the expected, and these were rosemary + dog rose, broccoli + 
turmeric, and coffee + oregano. Although the combination of rosemary and dog rose 
did not statistically significantly increase EpRE-dependent luciferase activity, there 
may be some synergistic effect of these three extract combinations. On the contrary to 
these 3 combinations, 2 other combinations had an observed value > 30 % lower than 
the expected value, namely the combination of rosemary + oregano, and red wine + 
rosemary. For these combinations, there may be antagonistic effects between the 
extracts. The p-values of the comparison of the expected and observed value are 
correspondingly the lowest of all the combinations tested. 
As the first experimental setup for studying combinations of dietary plant extracts 
included only single concentrations of each extract, a new experimental setup 
including a wider range of concentrations was planned. The advantage of this setup is 
that it allows comparison of the dose-response relationships for the extracts added 
individually and in combination. Due to a high induction of EpRE-dependent 
luciferase activity and a large difference between the expected and observed value 
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observed, the combination of coffee and oregano was selected. Interestingly, when 
comparing the observed effect of the 1 + 1 mg/ml extract combination with the 
expected value, the observed was significantly lower than the expected. It thus 
appears to be an antagonistic effect of the coffee and oregano extracts at this 
concentration. Furthermore, at the combination of 3 + 3 mg/ml, the observed effect 
was nearly significantly lower than the expected, indicating a trend towards 
antagonism at this concentration. This is intriguing with respect to the observed trend 
towards synergy when tested at this concentration in the first experiments. The 
overall fold induction from the oregano extract was lower in this extended 
experiment compared to the first experiments, and this discrepancy seems account for 
the difference between these two sets of experiments. This underlines the difficulties 
of working with food extracts. 
Mechanisms behind induction of EpRE-dependent transcription by 
dietary plant extracts 
Since most previous studies on dietary plants and EpRE-dependent transcription, 
only a few mechanistic studies have investigated the induction of EpRE-dependent 
transcription by dietary plant extracts. For the dietary plant extracts containing 
phytochemicals of which a mechanism for EpRE-induction has been described, it 
may however be assumed that the induction will be at least partly mediated by the 
same mechanisms as their respective phytochemicals. It is, however, important to 
note that the dietary plant extracts may contain other compounds that could also 
affect regulation of EpRE-dependent transcription. 
A selection of the phytochemicals, including vitamins and minerals, that may be 
present in the extracts is presented in Table 6.1. 
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Table 6.1 A selection of phytochemicals in the dietary plant extracts (14;109;152;153) 
Food Phytochemicals (including vitamins and minerals) 
Broccoli Vitamin A 
Vitamin B1, B2, B3, B6 
Vitamin C 
Vitamin E 
Folic acid  
β-carotene 
Isothiocyanates (phenetyl isothiocyanates, sulphoraphane) 
Cyanides 
Thiocyanates 
Nitriles   
Cocoa Vitamin A 
Vitamin B1, B2, B6 
Vitamin B3 
Folic acid 
Flavanols 
Flavonols 
Anthocyanins 
Procyanidins 
Coffee Diterpenes (cafestol, kahweol) 
Caffeine 
Phenolic compounds (caffeic acid) 
Dog rose Vitamin C  
Flavonoids 
Phenolic acids 
Lycopene 
Oregano Phenolic acids (caffeic acid, coumaric acid, rosmarinic acid) 
Flavonoids 
Red onion Vitamin B1, B2, B3, B6 
Vitamin E 
Folic acid 
Quercetin 
Anthocyanidins 
Gallic acid 
Diallyl sulfide 
Red wine Flavonols 
Flavanols 
Resveratrol 
Rosemary Phenolic acids (caffeic acid, rosmarinic acid, caffeoyl derivatives) 
Phenolic diterpenes (carnosol, carnosic acid, epirosmanol) 
Thyme Phenolic acids (gallic acid, caffeic acid, rosmarinic acid) 
Phenolic diterpenes 
Flavonoids 
Tomato Vitamin A 
Vitamin B1, B2, B3, B6 
Vitamin C 
Vitamin E 
Folic acid 
Lycopene 
β-carotene 
Phytoene 
Phytofluene 
Flavanones 
Turmeric Curcumin 
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Induction of EpRE-dependent transcription has been suggested to be directed by 
modification of cysteine residues on Keap1, or by activation of cellular signalling 
systems regulating the Nrf2 translocation or transactivation, such as MAPK, PKC and 
PI3K (98). These mechanisms of action have been demonstrated for a number of 
phytochemical inducers of EpRE-dependent transcription, and some inducers appear 
to work through multiple mechanisms (e.g. sulphoraphane) (84;102). 
Induction of EpRE-dependent transcription by individual extracts 
A previous study has found a potent induction of EpRE-dependent transcription by a 
broccoli extract in EpRE-LUC HepG2 cells (129), and a broccoli extract was also 
shown to induce EpRE-dependent luciferase activity in this thesis. Broccoli contains 
high amounts of sulphoraphane, in addition to several vitamins, minerals, and other 
phytochemicals (Table 6.1). Sulphoraphane has been suggested to be an effective 
cancer preventive compound from several epidemiological studies (154;155). A mice 
study has shown that sulphoraphane is able to induce cytoprotective proteins such as 
GP, GSR, NQO1, GST, GCL, and ferritin in the small intestine, through an Nrf2 
activated EpRE-dependent transcription (116). By studies in cell lines, the Nrf2 
activation has been suggested to be mediated by an activation of JNK1 and ERK2 
(84;102), and inhibition of p38 MAPK (100). Since sulphoraphane is an electrophile 
component, it may also activate Nrf2 translocation by modification of Keap1 cysteine 
residues directly (62;84). 
A cocoa extract was recently found to induce cytoprotective proteins in HepG2 cells, 
and this was suggested to be mediated by an activation of the ERK1/2 pathway (156). 
In line with these studies, a cocoa extract was found to give a significant induction of 
EpRE-dependent transcription in the EpRE-LUC HepG2 cells in this thesis. Cocoa 
contains both vitamins, minerals, and several phytochemicals (Table 6.1), and several 
of its components may thus contribute to its induction of EpRE-dependent 
transcription. 
A previous study has showed an induction of EpRE-dependent transcription in 
EpRE-LUC HepG2 cells by a coffee extract (129), and this was confirmed here. A 
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study administrating coffee to mice found a significant induction of cytoprotective 
proteins in the liver and gastrointestinal tract of Nrf2-wild type mice compared to 
Nrf2-knock out mice, and this induction was further suggested to be mediated by the 
phytochemical compounds cafestol and kahweol (109) (Table 6.1). The mechanisms 
behind induction of EpRE-dependent transcription by coffee is not fully elucidated, 
but a study has shown that the degree of roasting may be an important determinant 
for the extent of the induction (151). 
Dog rose, containing vitamin C in addition to several phytochemicals (Table 6.1), 
has been shown to induce EpRE-dependent luciferase activity in HepG2 cells (fold 
change 1.9 at 15 mg/ml) (129). An induction of EpRE-dependent luciferase activity 
by dog-rose was also observed in this study. Lycopene has been shown to induce 
EpRE-dependent transcription (129) and up-regulation of cytoprotective proteins in a 
HepG2 cell line (113). Lycopene may therefore have contributed to the induction of 
EpRE-dependent transcription observed for the dog rose extract in this thesis. The 
mechanisms by which lycopene induce EpRE-dependent transcription are however 
not fully elucidated. 
An extract of oregano has been found to induce EpRE-dependent luciferase activity 
in HepG2 cells (129), and this result was confirmed in this study. Oregano contains 
several different phytochemicals, such as phenolic acids and flavonoids, which may 
be contributing to its induction of EpRE-dependent luciferase activity (Table 6.1). 
A red onion extract was recently tested and found to induce EpRE-dependent 
luciferase activity in HepG2 cells (fold change 1.2 at 15 mg/ml) (129), and an 
induction of EpRE-dependent luciferase activity by a red onion extract was 
confirmed in this thesis. Red onions contain a wide range of potentially bioactive 
compounds (Table 6.1), of which diallyl sulphide and quercetin have been shown to 
induce EpRE-dependent transcription. The organosulphur compound diallyl sulphide 
has been shown to induce the cytoprotective protein NQO1 in Nrf2-wild type but not 
in Nrf2-knock out mice, indicating an induction of EpRE-dependent transcription by 
 97
diallyl sulphide (112). The phytochemical quercetin has been shown to induce EpRE-
dependent transcription in HepG2 cells, potentially by modification of Keap1 (117). 
An extract of rosemary has been shown to induce of EpRE-dependent transcription in 
EpRE-LUC HepG2 cells (fold induction 2.4 at 3 mg/ml) (129), and an induction of 
EpRE-dependent luciferase activity of a rosemary extract was also observed in this 
thesis. Carnosol is found in high amounts in rosemary (Table 6.1), and studies 
conducted in a rat kidney cell line has shown that carnosol induce expression of HO-
1 by activating Nrf2 and inducing its association with EpRE (110). This was further 
indicated to be mediated by an up-regulation of the PI3K. The carnosol may therefore 
contribute to the induction of EpRE-dependent transcription observed for rosemary in 
this study, although rosemary may contain other EpRE inducing compounds as well. 
Thyme is a phytochemical-rich herb (Table 6.1), which has been shown to induce 
EpRE-dependent luciferase activity in HepG2 cells when administrated as an extract 
(129). This is in accordance with the thyme extract used in this thesis. As thyme 
contains several phytochemicals, there may be several contributors to its induction of 
EpRE-dependent transcription. 
In addition to its wide use as a spice, turmeric has been used as an anti-inflammatory 
and anti-bacterial agent in traditional Indian medicine (157). These properties have 
been ascribed to its phenolic phytochemical curcumin, which has been found to 
possess potent anti-inflammatory and antioxidant properties, which has also been 
investigated as a chemopreventive agent (158;159). Curcumin has been shown to up-
regulate cytoprotective proteins by stimulating Nrf2 translocation and DNA binding 
both in human hepatoma cells (103) and in mice (111). This up-regulation has further 
been suggested to be mediated by activation of PKC and p38 MAPK (103). Both 
curcumin and turmeric has been found to induce EpRE-dependent luciferase activity 
in HepG2 cells (fold change 2.2 at 3 mg/ml) (129), and an induction of EpRE-
dependent luciferase activity was confirmed in this thesis. Due to its content of 
curcumin, turmeric may induce EpRE-dependent transcription at least partly via the 
same pathways as curcumin. 
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Induction of EpRE-dependent transcription by extract combinations 
From the previously discussed mechanisms by which dietary plant extracts may 
induce EpRE-dependent transcription, it is apparent that incubation of cells with a 
combination of extracts may introduce a wide range of compounds with potential 
effects on the Nrf2/EpRE-pathway. These food extracts may contain a variety of both 
known and unknown inducer compounds. Their mechanisms of inducing EpRE-
dependent transcription can be through studied mechanisms of single compounds 
present in these extracts, but possibly by other compounds and other pathways as 
well. The effects of these compounds may either be enhanced or inhibited compared 
to the corresponding effects of each compound alone, leading to additive, synergistic 
or antagonistic effects. It is possible that a particular mechanism of acting may be 
saturated at high concentrations of a compound or if several compounds target the 
same point of the pathway, so that the induction of EpRE-dependent transcription 
will stagnate. 
By activating different targets in the pathways, combinations of compounds may 
potentiate and multiply the EpRE-activation. Compounds, such as sulphoraphane, can 
modulate the cysteine residues on Keap1, and thus abrogate the ubiquitination of 
Nrf2. If the combination additionally contains components that induce EpRE-
dependent transcription through cellular kinases, the induction of EpRE-dependent 
transcription mediated by the two extracts may be particularly strong. 
An additive or synergistic effect of foods on signalling pathways such as the 
Nrf2/EpRE pathway may provide beneficial health effects of dietary plants when 
consumed in the diet. So far, only a few studies have explored additive and 
synergistic effects of foods, and thus further research in this complex field of 
nutrition is warranted. 
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Comparison of FRAP value and EpRE induction of extracts 
It has become more and more accepted that phytochemicals exert functions in vivo 
extending beyond direct antioxidant properties. The induction of EpRE-dependent 
transcription of cytoprotective proteins appears to be mediated by compounds both 
with and without in vivo redox activity according to Dinkova-Kostova and co-
workers (62). 
Although the highest FRAP-value was measured for the oregano extract, and the 
lowest FRAP-value was measured for the broccoli extract, both induce EpRE 
relatively strong and to a quite similar extent. This is in line with the theory presented 
by Dinkova-Kostova and co-workers (62) that several compounds induce 
cytoprotective proteins independently of their redox activity, of which one example 
has been sulphoraphane. This observation may emphasize the importance of 
phytochemicals beyond their function as antioxidants. 
6.2.2 Effect of rosemary extract on EpRE-dependent luciferase 
activity in vivo  
The experiments in this thesis, as well as other studies (129), have indicated an 
induction of EpRE-dependent transcription by rosemary extract in vitro. To our best 
knowledge however, no previous studies have tested the effect of a rosemary extract 
on EpRE-dependent transcription in vivo. 
A significantly higher EpRE activity in the extract group as compared to the control 
was found 5h after gavage feeding. This timing is in accordance with previous similar 
studies administrating dietary plant extracts to transgenic EpRE luciferase mice 
(129;151). The statistically higher EpRE activity in the extract group as compared to 
the control group at 5h shows that rosemary extract has an effect on EpRE activity in 
vivo. 
We observed that the overall EpRE activity was slightly decreased relatively to the 
base line level in both groups during the 24h experimental period. Living organisms 
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have developed a fluctuating system called circadian rhythms, generating 24-h 
periodicities in various physiological and behavioural processes (160). It may 
therefore be assumed that the EpRE-dependent luciferase activity also may be 
affected by circadian system. Interestingly, the mice in the extract group seemed to 
maintain a higher EpRE activity, at least during the first 5h. 
From the ex vivo imaging, the extract group appeared to have a higher EpRE- 
dependent luciferase activity in both intestinal segments compared to controls, 
although not statistically significant. This observation is particularly interesting with 
respect to the increasing awareness of the local cytoprotective effects of 
phytochemicals in the intestine (12;51). Nrf2 is highly expressed in the intestine (83), 
and an induction of cytoprotective proteins in this segment may reduce damage 
elicited by potentially reactive compounds in food. This may contribute to the 
observed beneficial effects of phytochemicals in the intestine. 
6.2.3 Potential health effects of inducers of cytoprotective proteins 
The cytoprotective proteins are important to reduce damage by oxidants and 
electrophilic compounds within the body. The family of GSTs for example, are 
important contributors to the cellular biotransformation of electrophilic compounds 
(161). Some EpRE-induced cytoprotective proteins may further catalyze reactions 
that generate small direct antioxidant molecules. Examples of such proteins are HO-
1, generating carbon monoxide and biliverdin/bilirubin (162), and γGCS, catalyzing 
the rate-limiting step in the synthesis of GSH (163). EpRE-dependent transcription 
also up-regulates small molecule antioxidants directly, such as Trx; in addition to 
enzymes responsible for catalyzing the reduction of such small molecule 
antioxidants, such as ThR (62). The intrinsic network of cytoprotective proteins is 
thus very complex (Figure 6.2), and provides protection against damaging oxidative 
and electrophilic compounds at several levels. Induction of this system is therefore 
suggested to decrease the risk of cancer and other chronic diseases whose 
pathogenesis depends on oxidative stress and electrophilic toxicity. 
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Figure 6.2 Potential effects of EpRE-inducers (adapted from Dinkova-Kostova et al. (62)). 
EpRE-dependent transcription up-regulates several cytoprotective proteins, both small redox active 
proteins, e.g. Trx, and enzymes that catalyze reduction of the oxidized form of small redox active 
proteins, e.g. ThR. EpRE-dependent transcription may thus increase the reducing capacity of an 
organism, and reduce damage potentially caused by oxidative stress and electrophiles. 
Originally the inducers of EpRE-dependent transcription of cytoprotective proteins 
were divided into two different categories: the bifunctional inducers, and the 
monofunctional inducers (section 1.4.3). Due to the potential activation of pro-
carcinogens by the cytochrome P450 enzymes up-regulated by the bifunctional 
inducers, the monofunctional inducers have been hypothesized to be more beneficial 
(71). Studies have further shown that a number of monofunctional inducers, e.g. 
sulphoraphane (164), may inhibit certain cytochrome P450 enzymes (165). This may 
thus additionally increase the beneficial health effect of monofunctional inducers. 
In addition to induction of cytoprotective proteins, some inducers have been found to 
be strong antioxidants, e.g. curcumin (62). Inducers with antioxidant activity may 
therefore work as direct scavengers of reactive species in addition to up-regulating 
cytoprotective proteins, and thus increase the total cytoprotective effect provided by 
these inducers (62). 
Recently, there has also been increasing interest in a potential cross-talk between the 
transcription factor nuclear factor kappa B (NF-κB) and the Nrf2/EpRE signalling 
pathway (92). NF-κB regulates transcription of many genes involved in immune and 
inflammatory responses, such as proinflammatory cytokines, chemokines, and 
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enzymes that generate mediators of inflammation (92). Several compounds have been 
shown to inhibit NF-κB activity while inducing EpRE activity, e.g. sulphoraphane 
(166;167) and resveratrol (114;168). Lipopolysaccharide induced NF-κB activation 
has further been shown to be attenuated by the Nrf2 activators sulphoraphane and 
curcumin (95). It has therefore been hypothesized that these two signalling pathways 
may cross-talk, and such cross-talk has been suggested to be mediated through 
competition of the transcriptional co-factor CBP (92). Phytochemicals that are both 
inhibitors of NF-κB and activators of Nrf2 may have extensive beneficial health 
effects, by inhibiting detrimental inflammation processes in addition to up-regulating 
cytoprotective mechanisms. The strong indications from epidemiological studies of 
beneficial health effects of sulphoraphane and resveratrol may thus be at least partly 
explained by their dual function as inhibitors of NF-κB and activators of Nrf2. 
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7. Conclusion 
The aims of this thesis were to study the effect of dietary plant extracts on EpRE 
activity in EpRE-LUC HepG2 cells, both separately and in combinations, and to 
study the effect of a dietary plant extract on EpRE-dependent transcription in 
transgenic mice. 
Of the 3 separate extracts tested in HepG2 cells, only cocoa gave a statistically 
significant increase in EpRE activity. 
Of 11 extract combinations tested in HepG2 cells, 8 gave a statistically significant 
induction of EpRE-dependent transcription, and 7 of these were also statistically 
higher than one or both of the separately added extracts. The combinations appeared 
to exert additive effects on EpRE-dependent transcription, although some showed a 
trend toward a more synergistic or antagonistic effect. When coffee and oregano was 
tested in a wider range of concentrations, a trend towards antagonistic effect was 
observed. Thus, we found that there are mostly additive effects of combinations of 
dietary plant extracts on EpRE activity in vitro. 
In the in vivo experiment, we found a statistically higher EpRE-dependent 
transcription for the group of mice receiving rosemary extract 5h after extract 
administration, as compared to the mice receiving vehicle control only. Interestingly, 
in the in vivo experiments the intestine of the extract group appeared to have higher 
EpRE activity than the control group, although this difference was not statistically 
different. 
Additive effects of dietary plants may provide extensive beneficial health effects. By 
showing that there may be additive effects between dietary plants on induction of 
EpRE-dependent transcription, this thesis may contribute to a better understanding of 
the beneficial health effects of dietary plants. Further studies are however needed to 
elucidate the relationship between dietary plants and EpRE activity more thoroughly. 
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